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Abstract
Molecular and Physiological function of the mammalian CCR4-
NOT subunit CNOT9
Messenger RNA (mRNA) decay is an indisputable component of gene expression regula-
tion. In higher eukaryotes such as humans and mice, this process is mainly governed by
a multi-subunit protein assemblage known as the CCR4-NOT complex. The complex
is composed of a central scaffold CNOT1, regulatory subunits CNOT2 and CNOT3,
a catalytic core consisting of CNOT6, CNOT6L, CNOT7, and CNOT8 proteins, and
additional three subunits CNOT9, CNOT10, and CNOT11. In this study, I analyzed
the role of subunit CNOT9 in target mRNA decay in the context of mouse embryonic
development. CNOT9 knockout mice appear normal during onset of gastrulation, yet
exhibit severe growth and differentiation defects during mid-late gastrulation stages
(E8.5 to E9.5), accompanied by extensive cell death. Similar nature of phenotype was
also observed in epiblast specific CNOT9 deletion mutants, suggesting major contribu-
tion of epiblast lineage cells in determining knockout embryo phenotype. At the molec-
ular level, CNOT9 is primarily localized within the cytoplasm and bridges interactions
between the CCR4-NOT complex and the miRNA-RISC complex. Transcriptomic
analysis identified key determinants of gastrulation such as Nodal, Lefty1/2, Cfc-1 to
be significantly upregulated in CNOT9 KO embryos relative to controls. Among these
targets, Lefty2 mRNA expression was found to be post-transcriptionally regulated by
CNOT9. Reporter mRNA containing Lefty2 3'-UTR element had higher stability in
cells expressing CNOT1-binding-mutant form of CNOT9, compared to cells expressing
wild-type CNOT9. Finally, in-vitro experiments with CNOT9 KO embryonic stem
(ES) cells further substantiated the importance of gastrulation regulation via CNOT9.
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Chapter 1
Introduction and Literature Review
1.1 RNA metabolism and the CCR4-NOT complex
Eukaryotic gene expression is fundamentally perpetuated via regulation of messenger
RNA (mRNA) expression. Typically, mRNA is synthesized within the nucleus by a
process known as transcription, followed by translocation into cytoplasm for synthesis
of proteins, and eventually undergoes degradation. In addition to these, a majority of
cellular mRNAs undergo post-transcriptional regulation that influence mRNA length,
half-life, localization, and translation. Examples of post-transcriptional changes in-
clude splicing of pre-mRNAs, 5' end capping, polyadenylation, and most importantly
interactions with RNA binding proteins (RBPs). Further complexity emerges with the
influence of internal or external stimuli such as nutrients, chemical and morphogen
gradients, ligand-receptor interactions, stress etc.
RNA metabolism refers to the entire scheme of events starting from biogenesis to
turnover of RNA, including incumbent steps of regulation. A large body of cellular
machines mainly consisting of multimeric protein complexes help in orchestrating these
processes. One such cellular machinery is the cytoplasmic CCR4-NOT complex that
is primarily known to stimulate decay of target mRNAs via deadenylation of polyA
tail. In humans and mice, the core complex is composed of a central scaffold pro-
tein CNOT1, regulatory subunits CNOT2 and CNOT3, a catalytic core consisting
of CNOT6, CNOT6L, CNOT7, and CNOT8 proteins, and additional three subunits
CNOT9, CNOT10, and CNOT11. Combinations of these subunits have been classified
into four modules  the NOT module, the catalytic module, the CAF40 module, and the
NOT10-NOT11 module, based on their ability to associate with independently folding
α-helical domains on CNOT1 (Wahle and Winkler, 2013). The NOT module consists
of subunits CNOT2 and CNOT3 as a heterodimer bound to the superfamily homol-
ogy domain (SHD) of CNOT1 at the C-terminal end (Bhaskar et al., 2013, Boland
et al., 2013). The catalytic module is typically composed of two deadenylase sub-
units  CNOT7/8 and CNOT6/6L. CNOT7/8 interacts with middle portion of eIF4G
(MIF4G) domain of CNOT1 and in return also serves as a docking site for leucine-rich
repeat domains (LRR) of CNOT6/6L proteins (Basquin et al., 2012, Petit et al., 2012,
Draper et al., 1994, Dupressoir et al., 2001). The CAF40 module consists of CNOT9
bound to domain of unknown function 3819 (DUF3819) domain of CNOT1 protein
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(Chen et al., 2014, Mathys et al., 2014). Lastly, the NOT10-NOT11 module consists of
proteins CNOT10 and CNOT11 bound to N-terminal end of CNOT1 (Bawankar et al.,
2013, Mauxion et al., 2013). A schematic representing the architecture and assembly
of various subunits of the mammalian CCR4-NOT complex is depicted in Figure 1.1.
Figure 1.1: Architecture and assembly of the mammalian CCR4-NOT com-
plex. Protein-protein interactions allow assembly of subunits on different domains of
the central scaffolding subunit CNOT1. The N-terminal HEAT domain contributes to
formation of NOT10-NOT11 module, central MIF4G and DUF3819 domains assem-
ble the catalytic module and the CAF40 module respectively, while C-terminal SHD
domain forms the NOT module.
The complex is expressed in various cell types and tissues from early developmental
stages to adult life (Chen et al., 2011). Mechanisms behind recruitment of this ubiqui-
tously expressed complex to its targets has been extensively investigated. Based on the
current understanding, under homeostatic conditions, the basal activity of the complex
involves bulk non-specific deadenylation. Tob/BTG family of proteins play and impor-
tant role in guiding such processes. Tob interacts with CNOT7 subunit of the complex
via its N-terminal antiproliferative domain (Xu et al., 2014). Tob also contains PAM2
(Poly(A)-binding-protein-interacting Motif 2) element at its C-terminal, that allows
interaction with cytoplasmic Poly(A)-binding protein (PABPC), thereby facilitating
turnover of bound mRNA (Okochi et al., 2005, Ezzeddine et al., 2007, Funakoshi et
al., 2007). Unlike Tob, BTG1 and BTG2 proteins that lack PAM2 elements, play their
part by interacting with RRM1 domain of PABPC1 via their N-terminal antiprolif-
erative domains (Stupfler et al., 2016). However, under stimulation, protein-protein
interactions between RNA binding proteins and subunits of the CCR4-NOT complex
lead to preferential recruitment of bound transcripts resulting in targeted mRNA de-
cay. For instance, RNA binding protein Tristetraprolin (TTP) interacts with AREs
(AU-rich elements) within 3'UTR of Tnfα mRNA and mediates rapid mRNA decay by
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Figure 1.2: Involvement of CCR4-NOT complex in various forms of mRNA
decay via interactions with: (A) TOB and PABP in generic RNA decay processes (B)
SMG5-SMG7 heterodimer bound transcripts for nonsense mediated decay (C) tethered
RNA Binding Proteins (RBPs) for targeted mRNA decay (D) miRNA bound to AGO2
and GW182
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further interacting with decay complex subunit CNOT1 (Sandler et al., 2011, Fabian
et al., 2013). Likewise, loss of CNOT7 and TOB proteins leads to post-transcriptional
stabilization of Ucp1 mRNA thereby protecting mice from diet induced obesity, despite
being bound to RNA binding protein BRF1 (Takahashi et al., 2015). Other forms of
stimulation may involve intracellular response to mutations leading to production of
nonsense transcripts. In such scenarios, SMG5-SMG7 bound mRNAs get recruited to
the complex via interactions with CNOT8 (Loh et al., 2013). Another common form
of stimulation occurs via interactions between microRNA and target mRNAs leading
to translation suppression followed by mRNA decay coordinated via Ago2 and GW182
family of proteins (Valencia-Sanchez et al., 2006, Behm-Ansmant et al., 2006, Chen et
al., 2009). An example of this was observed in zebrafish embryos undergoing maternal
to zygotic transition, wherein a sudden increase in miR-430 levels strongly correlated
with decay of maternal mRNAs possessing miR-430-binding sites in 3'UTR regions
(Giraldez et al., 2006). A schematic of CCR4-NOT complex driven mRNA decay
mechanisms is shown in Figure 1.2.
Impact of the CCR4-NOT complex on RNA metabolism extends beyond the scope
of deadenylation dependent mRNA decay. Subunits of the complex intervene in a
variety of other cellular processes that include transcription initiation and elonga-
tion, mRNA quality control, mRNA export, translational quality control and protein
turnover. (Chapat and Corbo, 2014, Collart, 2016, Shirai et al., 2014, Miller and Reese,
2012). In fact, NOT subunits (Not1, Not2, Not3, Not4) were first discovered as nega-
tive regulators of transcription in yeast (Collart and Struhl, 1994, Collart and Struhl,
1993). Mutant yeast showed preferential increase in HIS3 mRNA expression driven by
TATA-less promoter element upon disruption of the canonical TATA-box containing
promoter. Hence the name Negative on TATA-less was attributed to these proteins.
This notion prevailed for many years until biochemical and mass spectrometric evidence
emerged in support of a cytoplasmic protein complex constituted by Not proteins and
other associated molecules such as CCR4 and CAF1, collectively contributing to mRNA
deadenylation (Tucker et al., 2001, Chen et al., 2001). Soon, studies in Drosophila and
mouse fibroblasts showed conserved nature of metazoan homologues of these proteins in
accomplishing deadenylation dependent mRNA decay (Temme et al., 2004, Yamashita
et al., 2005). These findings highlighted an intriguing new function to the complex, but
also raised doubts over its true function in regulation of gene expression. Furthermore,
in the case of yeast and other models used for characterization of CCR4-NOT subunits,
an overall increase in mRNA levels or accumulation thereof, may have resulted from a
cumulative effect of derepression of transcription as well as impairment of mRNA decay.
Over time, research advances in the field of CCR4-NOT biology presented additional
evidences of gene expression control. For instance, proteomics analysis in HeLa cells
showed interactions between subunits of the CCR4-NOT complex and components of
nuclear mRNA processing machinery that included nuclear pore complex proteins and
splicing factors (Lau et al., 2009). In the context of translation repression, tethering of
CAF1 (CNOT7) deadenylase to reporter mRNA was found to repress of cap-dependent
translation in Xenopus oocytes (Cooke et al., 2010). This was a case of deadenylation
independent translation repression as catalytically inactive form of CAF1 also showed
translation repression. Other modes of inducing translation repression either involve
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microRNAs or interactions between CNOT1 and DDX6, an activator of Dcp1-Dcp2
decapping factors (Meijer et al., 2013, Chen et al., 2014, Mathys et al., 2014). Despite
major focus in the direction of post-transcriptional regulation, reports indicating direct
role of CNOT subunits in transcription regulation also surfaced. In one such example,
promoter occupancy of CNOT3 was shown to regulate transcription of pluripotency
associated transcription factors such as c-Myc and ZFX in mouse embryonic stem cells
(Hu et al., 2009). Direct involvement of CNOT7 in transcription driven by activity of
nuclear hormone receptors have also been reported (Prevot et al., 2001, Nakamura et
al., 2004).
Understanding the role of CCR4-NOT complex and its subunits in overall gene ex-
pression regulation, requires a systems prospective. The idea of transcription-coupled
mRNA decay has recently been proposed in a study involving Snf1, the yeast ortholog
of AMP-activated protein kinase (Braun and Young, 2014). In addition to this, mRNA
degradation factor Xrn1 has been implicated in transcription-cum-translation of mR-
NAs encoding membrane proteins (Blasco-Moreno et al., 2019). Conversely, transcrip-
tion factors have also been directly implicated in guiding targeted mRNA decay. In
one such study, transcription factor ERG was reported to recruit CNOT2 to control
decay of mRNAs to RNA-binding protein RBPMS, thereby facilitating mitotic pro-
gression (Rambout et al., 2016). In addition to these higher order interactions, further
heterogeneity in complex activity is attributed to variability in subunit stoichiometry
and structural composition of the complex. For instance, expression of key subunits,
CNOT1 and CNOT3, is barely expressed in mouse kidney lysates compared to higher
abundance in brain or thymus tissue (Chen et al., 2011). Also, CNOT6L has ubiquitous
expression across tissues, while CNOT6 is selectively expressed in thymus, ovary and
testis, and spleen (Chen et al., 2011). Finally, it is important to delineate functional
contributions of individual subunits or a subset thereof, vs. collective function mediated
by the complex. For instance, many studies attributing role of individual CCR4-NOT
subunits within the nucleus, fail to provide comprehensive structural information of
the complex within the context of study. Also, mammalian CNOT4, previously under-
stood to be structurally and functionally disconnected from the complex, has recently
been shown to have affinity with the core complex duly supported by biochemical and
crystal structure based evidences (Keskeny et al., 2019, Yang et al., 2016). In summary,
the CCR4-NOT complex acts as a guardian of gene expression control by directly or
indirectly influencing various cellular machinery that are individually responsible for
specific function.
1.2 Physiological relevance of the CCR4-NOT com-
plex
Manifestation of molecular events at the physiological level has always been an in-
triguing field of research. In the past, many examples of functional redundancy were
observed in case of protein kinases, initially characterized to have definitive molecular
function (Saba-El-Leil et al., 2016, Voisin et al., 2010). Furthermore, complex mul-
ticellular eukaryotes exhibit higher order gene expression regulation with intra-organ
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and inter-organ crosstalk between various cell types. It is therefore worth investigating,
the importance of a given molecule (protein) or biochemical pathway in the context
of physiology at various levels of organization  cells, tissues, organs, and organ systems.
In higher eukaryotes such as mice and humans, the CCR4-NOT complex and its
subunits have been found to regulate gene expression across a variety of different phys-
iological processes such as germ layer differentiation, nervous system development,
spermatogenesis, immune regulation, adipose and cardiac tissue development, to name
a few (Nakamura et al., 2004, Yamaguchi et al., 2018, Joly et al., 2013, Koch et al.,
2014, Inoue et al., 2015, Takahashi et al., 2019, Sohn et al., 2015). This falls in agree-
ment with the diversity of molecular activity the complex orchestrates at the cellular
level. For example, mice deficient in CNOT7 show impairment in spermatogenesis due
to defects in testicular somatic cells (Nakamura et al., 2004). Haploinsufficiency of
CNOT3 in mice leads to enhanced metabolic rates resulting in high glucose tolerance
and resistance against diet-induced obesity (Morita et al., 2011). In another example,
conditional depletion of the CCR4-NOT complex components CNOT1 or CNOT3 re-
sults in cardiomyocyte death triggered by elongation of poly(A) tail of Atg7 mRNA
(autophagy regulator) and activation of p53 (Yamaguchi et al., 2018). Likewise, over
the past two decades, many examples of physiological function have been attributed
to mice and human subunits CNOT1, CNOT2, CNOT3, CNOT6, CNOT6L, CNOT7,
and CNOT8. However, very limited information exits with regard to subunits CNOT9,
10 and 11. Our laboratory generated knockout (KO) mice for various subunits and
observed phenotypes as listed in Table 1.1.
Gene Phenotype References
Cnot1 Embryonic lethal<E6.5 Unpublished
Cnot2 Embryonic lethal Unpublished
Cnot3 Embryonic lethal<E6.5 (Neely et al., 2010, Morita et al.,
2011)
Cnot6 Normal at birth (Dominick et al., 2017)
Cnot6l Resistant to HFD in-
duced obesity
(Morita et al., 2019)
Cnot7 Male sterility, increased
bone mass
(Nakamura et al., 2004, Washio-
Oikawa et al., 2007)
Cnot8 Embryonic lethal ≈ E8.5 Unpublished
Cnot4, 9, 10, 11 Embryonic lethal Unpublished
Table 1.1: Phenotype exhibited by KO mice deficient of CCR4-NOT subunits
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A spectrum of different phenotypes exhibited by mice upon depletion of CCR4-NOT
subunits (as shown in Table 1.1), which emphasizes the requirement of the complex
during early developmental stages. Causes of lethality can be postulated in terms
of disruption in RNA homeostasis resulting from impairment in complex structure
and/or function. In fact, beyond direct purview of the CCR4-NOT complex a large
body of evidence endorses the importance of RNA regulation during development. For
instance, fission yeast selectively eliminates meiosis-specific transcripts during vegeta-
tive growth stages to prevent untimely entry into meiosis (Harigaya et al., 2006). In
Drosophila oocytes, pre-zygotic anterior-posterior axis specification is primarily driven
by cytoplasmic compartmentalization of bicoid and nanos mRNAs (Ferrandon et al.,
1997, Macdonald and Kerr, 1998). Embryos lacking Bicoid protein cannot form the
fly head, whereas ectopic expression of bicoid mRNA at the posterior end result in
two-headed embryos (Driever et al., 1990). During late gastrulation stages of mice
embryos, anterior-posterior patterning occurs as a result of Fgf8 mRNA decay in an-
terior regions (Dubrulle and Pourquie, 2004). In one of the better-known examples,
oscillations in levels of cyclin transcripts guide cell cycle kinetics in mitotically active
cells, while lack of adequate induction directs post-mitotic cell fate (Pines and Hunter,
1989, Maity et al., 1995). These and many more examples emphasize the importance
of regulated RNA synthesis, localization, transport, and decay across various stages of
development and differentiation.
A few studies showcasing direct functional role of CCR4-NOT subunits during
development have been reported. For instance, CNOT1, CNOT2, and CNOT3 have
been shown to maintain mouse and human embryonic stem cell identity via inhibition of
Cdx2, Gata3, Eomes, and Krt8 transcripts that promote extraembryonic differentiation
(Zheng et al., 2012). CNOT3 depletion in mouse embryonic fibroblasts (MEFs) has
been shown to promote necroptosis via stabilization of cell-death related transcripts
(Suzuki et al., 2015). Interaction between RNA binding protein NANOS2, and CNOT1
was found to be critical for development of male germ cells in mice (Suzuki et al.,
2010, Suzuki et al., 2012). Loss of Caf1 (CNOT7) in worms, leads to impairment in
larval development with defects in progression of gametogenesis in both males and
hermaphrodites (Molin and Puisieux, 2005). CNOT8 mutant fish lacking majority of
RNAse domain due to a point-nonsense mutation, show compromised development of
dopaminergic neurons in caudal hypothalamus region of the brain due to stabilization
of Fgf3, Fgfr1/2/3/4 and their downstream effectors (Koch et al., 2014). CNOT3
post-transcriptionally regulates decay of Cdkn2a mRNA and other cyclin-dependent
kinase inhibitors (CDKIs), thereby abetting proliferation of cardiomyocytes derived
from human embryonic stem cells (Zhou et al., 2017). Lastly, deadenylase activity
of the CCR4-NOT complex has recently been implicated in decay of hairy-related
transcripts during zebrafish somitogenesis (Fujino et al., 2018). Beyond these handful
set of examples, direct involvement of CCR4-NOT subunits in vertebrate development,
has not been comprehensively demonstrated. Therefore, understanding the role of
uncharacterized subunits such as CNOT9 having developmental phenotype was an
ideal choice for study. In the following section, existing literature concerning CNOT9
8 Introduction and Literature Review
shall be introduced, before stating the objectives of this study.
1.4 CNOT9 (Rcd1/Rqcd1/Caf40)
Identification, Characterization, and Function
CNOT9 (or RQCD1 or RCD1 or CAF40) was first identified as a factor responsible
for inducing sexual differentiation in the fission yeast Schizosaccharomyces pombe, un-
der conditions of nitrogen starvation (Okazaki et al., 1998). Thereafter, using mass
spectrometry, it was confirmed to be a part of yeast CCR4-NOT complex (Chen et al.,
2001). The monomeric form is a 33 kilodalton (299 amino acids) polypeptide consisting
of six armadillo repeat (ARM) domains, capable of binding single and double stranded
oligonucleotides (Garces et al., 2007, Chen et al., 2014, Mathys et al., 2014). CNOT9
protein is highly conserved from yeast to humans with over 70% amino acid sequence
identity (Okazaki et al., 1998, Garces et al., 2007).
Ste11 was one of the first downstream targets of CNOT9 identified in Schizosaccha-
romyces pombe (Okazaki et al., 1998). It codes for a transcription factor that controls
sexual differentiation conjugation followed by meiosis and sporulation, under nutrient
stress conditions (Kelly et al., 1988, Sugimoto et al., 1991). In absence of CNOT9,
yeast cells were sterile under nutrient stress conditions, whereas rescue of fertility oc-
curred via ectopic expression of Ste11 (Okazaki et al., 1998). Yeast Ste11 contains
N-terminal HMG box (high mobility group) characteristic of HMG boxes present on
Tcf-1/Lef-1 proteins in higher eukaryotes (Okazaki et al., 1998, Yamamoto et al., 1999).
Such structural and functional homology raises the odds for CNOT9 role in processes
such as T-lymphocyte differentiation.
Mammalian CNOT9 was first reported as a nuclear co-factor involved in retinoic
acid (RA) induced differentiation of F9 teratocarcinoma (testicular cancer) cells (Hiroi
et al., 2002). Knockdown of CNOT9 using anti-sense oligomers, displayed an impair-
ment in RA induced differentiation of F9 cells (Hiroi et al., 2002). This study also
highlighted the role of CNOT9 in RA induced complex formation between Retinoic
acid receptor (RAR) and Activating Transcription factor 2 (ATF-2) at differentiation-
specific enhancer (DRE) elements of the c-jun promoter (Hiroi et al., 2002). DRE
element occupancy by RAR-CNOT9-ATF-2 complex resulted in an increase in c-jun
expression, thereby leading to differentiation of F9 cells to visceral endoderm cells (Hi-
roi et al., 2002). In a study conducted on human cell lines, CNOT9 was reported
as a transcriptional repressor for C-MYB and AP-1 target genes (Haas et al., 2004).
C-MYB and AP-1 are transcription factors that associate with RNA Polymerase II to
form pre-initiation complexes at target promoters. Nuclear C-MYB protein, via phys-
ical interactions with CNOT9 was found to repress mim-1 promoter activity (Haas et
al., 2004). In a later study, based on yeast-two hybrid assay, CNOT9 was reported
to enhance transcriptional activity of nuclear hormone receptors such as TRα, RARα,
and RXRα, via direct interactions with NIF-1 protein in HeLa cells (Garapaty et al.,
2008). However, results presented by this study need further validation in physiologi-
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cal contexts, since knockdown of CNOT9 didn't have a profound effect on endogenous
targets of nuclear hormone receptors such as Hoxa1 and Sox9.
In-vivo function of CNOT9 has been reported in RA dependent embryonic lung
development (Hiroi et al., 2002). CNOT9 expression increased upon RA induction
leading to inhibition of branching morphogenesis of alveolar lung, while its subsequent
knockdown restored branching leading to formation of distal alveolar buds (Hiroi et al.,
2002). A schematic of RA dependent lung development potentially involving CNOT9,
is summarized in Figure 1.3.
Figure 1.3: Schematic of RA induced branching morphogenesis of embry-
onic lung
In-vitro studies using human and Drosophila cell lines have identified CNOT9 to
mediate stable protein - protein interactions between subunits of the CCR4-NOT com-
plex and miRNA-RISC complex. Crystal structure analysis showed CNOT9 bound to
DUF3819 domain of CNOT1 provided docking sites for W(tryptophan)-rich residues
present on TNRC6 proteins (Mathys et al., 2014, Chen et al., 2014). These studies
project possible contribution of CNOT9 in miRNA mediated translational repression
and decay. In addition, human CNOT9 bound to CNOT1 was found to stimulate
deadenylation driven by a nuclease module consisting of BTG2, CNOT6L, and CNOT7
(Pavanello et al., 2018). CNOT9 has also been found to recruit the complex to TTP
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(Tristetraprolin) bound mRNAs, thereby contributing to decay of reporter RNA (Bul-
brook et al., 2018). Drosophila Roquin was shown to interact with the CCR4-NOT
complex via multiple and partially redundant interactions, one of which occurs via
interaction with CNOT9 (Sgromo et al., 2017). A unique but poorly conserved short
linear motif located at the c-terminal end of Roquin was deemed necessary and suffi-
cient for interaction with CNOT9 (Sgromo et al., 2017). In another study, Drosophila
Bag-of-marbles (Bam) protein has been shown to exclusively interact with CNOT9 sub-
unit of the CCR4-NOT complex and facilitate both translation repression and decay of
polyadenylated mRNAs, in-vitro (Sgromo et al., 2018). Human and Drosophila CNOT4
proteins have recently been found to possess a conserved motif that allows weak, yet
direct interaction with CNOT9 protein (Keskeny et al., 2019). The study also revealed
that both depletion of CNOT9 or disruption of CNOT4-CNOT9 interaction, leads to
impairment in CNOT4 directed decay of tethered reporter RNA (Keskeny et al., 2019).
Lastly, in a recent in-vitro reconstitution study, human CNOT9 was postulated to serve
bipartite function in facilitating bulk nonspecific decay as well as targeted decay by
interacting with substrate RNA or RNA binding proteins respectively (Raisch et al.,
2019).
CNOT9: Expression and Localization
Tissue wide expression studies showed a preferential expression of CNOT9 during em-
bryonic stages over post-natal adult stage tissues (Hiroi et al., 2002). CNOT9 expres-
sion has been noted in embryonic rat tissues such as the brain, liver, lung, intestine,
heart, kidney, thymus and spleen (Hiroi et al., 2002). However, its expression reduces
considerably in adult rats with detectable levels found only in spleen, thymus, testis,
bone marrow and lung (Hiroi et al., 2002). In humans, northern blotting analysis was
used to detect CNOT9 expression in testis, prostate glands, thymus, ovaries, small
intestine, mucosal lining of the colon, and peripheral blood leukocytes (Okazaki et al.,
1998, Haas et al., 2004, Ajiro et al., 2009). In addition, a steep increase in mRNA
expression was also noted in certain cases of breast cancer (Ajiro et al., 2009). These
results suggest a correlation between CNOT9 expression and tissues undergoing or
supporting active cellular differentiation.
Although it seems quite intuitive to predict CNOT9 localization, given its roles
in nucleus and cytoplasm, certain reports have narrated biased inferences. CNOT9
was initially reported to be localized primarily within nuclei of COS-7 cells (Haas
et al., 2004). This was in agreement with contemporary reports that identified its
role in transcription repression. Later it was also identified as part of the cytosolic
CCR4-NOT complex and yet another cytosolic complex containing GIGYF1/GIGYF2
proteins (Ajiro et al., 2009, Ajiro et al., 2010). Despite lacking a canonical nuclear
localization signal sequence, CNOT9 localizes within the nucleus, by mechanisms that
remain to be elucidated.
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1.5 Research Objective
The purpose of this work is to investigate physiological role of mammalian CNOT9,
using complete and conditional knockout mice models. Based on phenotype exhibited
upon CNOT9 loss, molecular targets of CNOT9 at the level of transcription and/or
mRNA decay, shall be identified. Furthermore, identified targets shall be validated
using in-vitro cell culture-based assays. At the biochemical level, the degree of require-
ment for CNOT9 in terms of inter-complex and intra-complex interactions shall be
investigated. In summary, novel perspectives of the CCR4-NOT complex in the con-
text of RNA metabolism shall be investigated from the standpoint of subunit CNOT9
as listed below:
Aim 1: Investigating phenotype of knockout mice to identify
molecular targets and pathways regulated by CNOT9.
Aim 2: Understanding biochemical interactions of CNOT9, and
role in translation repression and mRNA decay.
Aim 3: Identification of CNOT9 targets in mouse embryonic stem
cells under conditions that promote self-renewal vs. lin-
eage specific differentiation.
The above three aims shall be addressed individually in Chapters 2, 3, and 4,
respectively
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Chapter 2
Role of CNOT9 in mouse embryonic
development
2.1 Motivation
The relevance of a biochemical pathway, molecular mechanism, or a component thereof,
can be best examined by studying its physiological significance. Over the past few
decades, laboratory mouse has been serving as an excellent model to study genes and
pathways related to human development and disease. This was largely facilitated by
two techniques  gene trapping and gene targeting in mouse ES cells, that were devel-
oped during the late 1980s and gradually perfected over the next two decades (Stanford
et al., 2001, van der Weyden et al., 2002). With the help of gene-targeting technique, a
given locus in the mouse genome can be engineered to generate transgenic/knockout/knock-
in mice. We used gene-targeting technique we could successfully disrupt the mouse
CNOT9 locus and generate heterozygous (HE) mice.
Although CNOT9 has long been identified as part of the CCR4-NOT complex,
there have been no reports suggesting direct targets of CNOT9 either at the level of
translation repression, or mRNA decay. With our approach, we aimed to identify de-
cay targets of CNOT9 that showed increased mRNA stability and expression in KO
mice tissues. KO mouse also allows us to investigate indispensability or functional
redundancy of CNOT9 in various processes of gene expression regulation that have
previously been reported in literature. These include roles in mRNA decay either via
the microRNA pathway or via interactions with RNA binding proteins.
In this chapter, we investigated the physiological function of CNOT9 by analyzing
phenotype exhibited by KO mice. Results obtained from in-vivo studies were tested
using in-vitro culture-based conditions to validate existing models and theories per-
taining to gene expression control via CNOT9.
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2.2 Materials and Methods
2.2.1 Animals (Cnot9+/lacZ, Cnot9+/loxP , and Cnot9+/loxP Sox2-
Cre mice)
Both Cnot9+/lacZ and Cnot9+/loxP mice were generated and provided by from RIKEN
Center for Developmental Biology, Japan. In the process of generating Cnot9+/lacZ
mice, Exon 1 of the Cnot9 locus was targeted and replaced by LacZ and neomycin re-
sistance gene via electroporation of TT2 ES cells (Yagi et al., 1993). Neomycin-resistant
ES cell clones harboring homologous recombination were injected into ICR 8-cell-stage
embryos to generate chimeric mice. Germline-transmitted male chimeras were crossed
with C57BL/6J female mice to obtain heterozygous F1 offspring. Gene targeting strat-
egy used to generate Cnot9+/lacZ mice is shown in Figure 2.1A and genotyping primers
are listed in Table 2.1. Cnot9 conditional (Cnot9+/loxP ) mice were also generated sim-
ilarly by targeting TT2 ES cell lines. To generate conditional alleles (floxed alleles)
from targeted alleles, mice with targeted alleles were crossed with transgenic mice ex-
pressing FLP enzyme. Gene targeting strategy used to generate Cnot9+/loxP mice is
shown in Figure 2.1B and genotyping primers are listed in Table 2.1. Experiments
were performed with mice that had been backcrossed successively to C57BL/6J mice
for at least seven generations. Cnot9+/loxP Sox2-Cre mice were generated by crossing
Cnot9+/loxP female mice with Sox2-Cre transgenic males. It is important to use CRE
expressing male mice since maternal expression of Cre would lead to systemic deple-
tion of floxed allele, leading to loss of cell-type specificity. Animals were maintained in
12-hour light dark-cycle within temperature-controlled (22oC) barrier facility provided
with abundant supply of Rodent Diet CA-1 (CLEA, Japan) and water. All experi-
ments were carried out following guidelines for animal use issued by Animal Resources
Section, OIST and the Institutional Animal Care and Use Committee (IACUC) at
RIKEN Center for Developmental Biology.
2.2 Materials and Methods 15
Figure 2.1: Gene targeting strategies adopted for generation of transgenic
mice (A) LacZ knock-in mouse by targeting exon1 of Cnot9 genomic locus (B) Cnot9
conditional mouse by targeting exons 2 and 3 of Cnot9 genomic locus.
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Mouse
line
Primers (5' -3') Product
size
Cnot9+/lacZ
TTATCTGGACGCGGGTTGTGAATGCTGG
416 bps (WT
band), 296 bps
(KO band)
ACTAGTTCTAGAGCGGCCGATTTAAATACG
GTCCTAAGAAAGACATTCCAGGTAGAG
Cnot9+/loxP
CATGGGCTCATTAGCTGTCAAACAGGTTGAG 423 bps (floxed
band), 212 bps
(WT band)CCACTGATAGATCTTCTCTCTGTCCACTTGG
Sox2-Cre
TCGATGCAACGAGTGATGAG
482 bps
TTCGGCTATACGTAACAGGG
IL2
(Internal
control)
CTAGGCCACAGAATTGAAAGATCT
324 bps
GTAGGTGGAAATTCTAGCATCATCC
Cnot9+/loxP
Sox2-Cre
GCTAGGTAGACAAAGGACTTCAGG 271 bps (WT
band) 546 bps
(Recombined
band)
CCAACCTTGACAGCACACCAGTCTAAC
CCATACACTACATTGCATCTCCTTTCCCTAG
Table 2.1: Genotyping primers used for various mouse lines alongside PCR
product size
2.2.2 Mice Genotyping
Tail tips from three-week-old mice within 1.5ml Eppendorf tubes were lysed in 50µl
of lysis Solution I (25mM NaOH in 0.2mM EDTA) at 95oC for 15 minutes. This was
followed by addition of 50µl of lysis Solution II (40mM Tris-HCl, pH=7.5). Thereafter,
samples were vortexed for 10 seconds, centrifuged at 120,000g for 3 min at 4oC. 0.75µl of
lysate supernatant was used as template for PCR based genotyping. Same protocol was
used for genotyping E9.5 stage and older embryos using yolk-sac tissues. For embryos
prior to E9.5 stage, Phire Tissue Direct PCR Kit (Invitrogen) was used following
manufacturer's protocol with minor modifications. Briefly, 15µl of Dilution Buffer
(kit) was added to tissue samples collected in 1.5 ml Eppendorf tubes, followed by
addition of 1µl of DNARelease Additive (kit). Samples were mixed by vertexing 5-10
seconds followed by quick spin on a table-top centrifuge. Samples were then rested for
5 minutes at room temperature, followed by boiling at 98oC for 3 minutes. Finally,
after another quick spin, samples were rested on ice. Genotyping was done using 1µl
of lysate. Composition of PCR mixture is tabulated below:
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Sl. No Particulars Volume
1 10 X Taq Buffer (+MgCl2) 2µl
2 2.5 mM dNTP 2µl
3 FP 0.4µl
4 RP1 0.4µl
5 RP2 (optional) 0.4µl
6 Taq Polymerase 0.1µl
7 dH2O ≈13.7 µl
8 Template DNA ≈1µl
Total 20µl
PCR cycles
Initial Denaturation 95oC 2 mins
Denaturation 95oC 20 sec
Annealing 60oC 30 sec ×35 cycles
Extension 72oC 30 sec
Final Extension 72oC 3 mins
Resting condition 4oC End
Finally, 10µl of PCR product in 1x loading dye, was resolved on 2% agarose gel.
2.2.3 Cell culture
HeLa cells were cultured in DMEM (low Glucose) media containing 10% fetal bovine
serum (FBS). TransIT-LT1 (Mirus Bio) reagent was used for transient transfection
assays based on manufacturer's protocol. For determination of reporter mRNA half-
life kinetics CNOT9 KO HeLa cells were first transfected with flag-CNOT9 (wild-type)
or flag-CNOT9mut4 (mutant), for 24 hours, followed by transfection of luciferase-Lefty2
3'-UTR, luciferase-Lefty1 3'-UTR, or luciferase-c-myb 3'-UTR constructs for 4 hours.
Cells were then treated with 2.5µg/ml ActinomycinD (Wako) for 6 hours with samples
being collected at 0, 3, and 6 hours post treatment.
2.2.4 Western Blotting
Mouse Embryo
Protein lysates from individual or pooled sets of embryos were prepared by homogeniza-
tion (using Fisherbrand Pellet Pestle) in TNE buffer. Buffer composition is tabulated
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as follows:
Sl. No. Component Volume Final Concentration
1 1M Tris-HCl (pH = 7.5) 10 ml 20 mM
2 5M NaCl (autoclaved) 15 ml 150 mM
3 NaF 0.21gm 10 mM
4 Beta-glycerophosphate 1.53 gm 10 mM
5 EDTA 0.29gm 2 mM
6 NP40 (from bottle) 5 ml 1%
7 200mM PMSF 2.5ml 1 mM
8 MQ water Up to 500 ml
After preparation, solution was filter sterilized and stored at 4oC until use.
Lysates were incubated on ice for 15 minutes, with gentle pulse vertexing every 5
minutes, followed by centrifugation at 130,000g for 10 min at 4oC. Supernatant was
transferred into fresh Eppendorf tubes protein concentration was determined using
Pierce BCA assay kit (ThermoFisher). Based on results from BCA assay, lysates con-
centration was adjusted to a final concentration of 1µg/µl in 1X Sample Buffer (50mM
Tris-HCl pH= 6.8, 2% SDS, 0.1% Bromophenol Blue, 10% Glycerol). Lysates were
boiled at 95oC for 5 minutes and allowed to cool to room temperature for 10 min-
utes. Depending on molecular weight of the protein to be examined, 6% to 12.5%
SDS-PAGE gels were prepared. Lysates were subjected to electrophoresis at 130V
until desired ladder separation is achieved within resolving region of gels. Separated
proteins on the gel were then electro-transferred onto 0.45um Polyvinylidene difluo-
ride (PVDF) membranes (Millipore). Transfer was done at 12V (constant voltage) for
720 minutes using wet transfer system (Nihon-Eido). Post transfer, membrane was
subjected to blocking using 5% skimmed milk in TBST (20 mM Tris, 150 mM NaCl,
0.05% Tween-20) solution for 45 to 60 minutes at room temperature (RT). Membranes
were then incubated with primary antibody solution for 2 hours at RT, followed by
1hour of incubation with appropriate horse radish peroxidase (HRP) conjugated sec-
ondary antibody (1:4000 dilution). Upon completion of each antibody incubation step,
membranes were washed 3 times (5 minutes each) in TBST solution with gentle shak-
ing, to remove non-specifically bound antibodies. Finally, proteins of interest were
probed by detecting chemiluminescence intensity using Image Analyzer LAS 4000 (GE
Healthcare). Data was analyzed and quantified by applying area calculator tool over
a rectangular selection of protein bands using ImageJ software.
Cultured cells (in-vitro):
As a first step towards isolation of protein lysates from cells grown in culture dishes,
appropriate volume of TNE buffer was added to wells, after performing media aspi-
2.2 Materials and Methods 19
ration followed by two PB washes. Thereafter, with the help of a cell scraper, cells
were detached from the bottom surface of wells/dishes. Using a pipette man, lysate
was collected into individual Eppendorf tubes on ice. Lysates were rested on ice for 15
minutes with gentle pulse vortexing every 5 minutes. Thereafter, similar steps for pro-
tein isolation and quantification were performed as mentioned in the previous section
for mouse embryos.
2.2.5 Antibodies
Antibodies against CNOT1 and CNOT3 were generated by Bio Matrix Research (Tokyo,
Japan) and previously described previously (Chen et al., 2011). Commercially avail-
able antibodies used in this study included: anti-a-tubulin (Sigma, T9026), anti-PARP
(CST, 9542S), anti-CNOT9 (Proteintech, 22503-1-AP), anti-FLAG (MBL, PM020),
anti-XRN1 (Bethyl A300-443A), anti-HistoneH3 (CST, 4499S), anti-GW182 (Bethyl,
A302-329A), anti-CNOT2 (CST, 34214S), anti-4EBP1 (CST, 9644S), anti-b-Actin (CST,
4970L), anti-GAPDH (CST, 2118L), anti-CNOT10 (Bethyl A304-899A), and anti-
AGO2 (CST, 2897S). For western blotting, all antibodies were used at 1:1000 dilution
in 5% skimmed milk solution.
2.2.6 Protein Immunoprecipitation
Protein lysates from E8.0 - E8.5 embryos were prepared and quantified as mentioned
in section 2.2.4. 2mg of total protein was subjected to immunoprecipitation using
anti-CNOT3 antibody or Control Mouse IgG (Santacruz, SC-2025) for 1 hour at 4oC,
followed by an additional 1-hour incubation with 50µl of Dynabeads (Invitrogen) added
directly to the antibody-lysate solution. Incubation was done using a rotating mixture
apparatus located in cold room area (4oC). Immunoprecipitated proteins were recov-
ered by magnetic separation of bead-antibody-protein complex. Magnetically separated
complexes were washed 5 times before final elution. Elution was done in 40-50µl of
1X Sample Buffer (containing 2-ME) upon heating at 95oC for 5 minutes. Thereafter,
samples were centrifuged at 1500g, for 1 min at 4oC. Supernatant containing immuno-
precipitated proteins were transferred into fresh Eppendorf tubes and stored at -30oC
until further use. Loading volumes for Input and IP fractions were determined and
accordingly resolved on SDS-PAGE gels. HeLa cell lysates obtained after transfecting
cells with flag-CNOT9 or flag-CNOT9mut4 or pcDNA3.0 vectors were subjected to im-
munoprecipitation using ANTI-FLAG M2 Affinity gel (Sigma) for 2 hours at 4oC. Prior
to addition of antibody conjugated beads to lysates equilibration steps was performed.
Briefly, 1 ml of bead-antibody gel was aliquoted into a 1.5 ml Eppendorf tube and
centrifuged at 1500g for 1 min at 4oC. Post centrifugation, supernatant was discarded
and 1 ml of TNE Buffer was added to resuspend antibody-bead pellet. Gentle pipet-
ting was done to make a homogenous solution and thereafter centrifuged at 1500g for
1 min at 4oC. Once again, supernatant was discarded and washing step was repeated
2 more times. Finally, at the end of final spin, 500µl of TNE buffer was added to
existing beads that occupy volume equivalent of 500µl. This ensures an approximate
bead concentration of 50%. In this form, antibody-conjugated beads can be stored at
4oC for a maximum of 6 months. Approximately 40µl of pre-equilibrated M2 beads
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per aliquot of protein lysate was used. Upon conclusion of 2-hour incubation, lysates
were centrifuged at 1500g, for 1 min at 4oC. Supernatant containing unbound proteins
was discarded and replaced with 1ml of TNE buffer. Loosely attached pellet at the
bottom of the tube was mixed by gentle pipetting, followed by centrifugation at 1500g,
for 1 min at 4oC. This washing step was repeated for an additional 4 times. At the
end of last wash, 30µl of FLAG peptide (1µg/µl) was added to pellet and incubate at
37oC for 10 minutes. Thereafter, samples were centrifuged at 2500g, for 1 min at 4oC
and supernatant was aliquoted into freshly labelled tubes. Finally, 15µl of 3X Sample
Buffer (containing 2-ME) was added to immunoprecipitated lysates and heated at 95oC
for 5 minutes. Samples were allowed to cool to RT before storage at -30oC until use.
All lysates were subjected to BCA assay prior to IP, to ensure equal amount of starting
material.
2.2.7 RNA Isolation and qRT-PCR analysis
All RNA extraction was done using ISOGEN II (Nippongene) reagent according to
manufacturer's protocol.
Mouse embryos:
E7.5 to E8.5 stage embryos were individually collected in 1.5 ml Eppendorf tubes
containing 300µl of Isogen II reagent. Samples were stored at -80oC, until genotype
of each sample was determined by PCR. Typically, 3 embryos of the same genotype
were pooled into one tube. Before RNA isolation, embryo samples in Isogen solution
were homogenized by passing through 26G needle. After homogenization, 100µl of
additional Isogen II reagent was added to make a final volume of 1ml. Thereafter,
400µl of RNase free water was added to tissue homogenate and vortexed vigorously
for 15 seconds. Samples were then allowed to rest at RT) for 8 minutes, followed by
centrifugation at 13,000g for 15 minutes at 4oC. 950µl of supernatant was transferred
to a 2ml Eppendorf tube containing equal volume of Isopropanol, followed by addition
of 1.5µl GlycoBlue (ThermoScientific). Thereafter, samples were mixed by inversion
(8-10 times) and left at RT for 10 minutes. Upon conclusion of this step, samples
were centrifuged at 13,000g for 10 minutes at 4oC. Supernatant was discarded, and
blue colored pellet was washed with 500µl of 75% Ethanol (in MQ water) followed by
centrifugation at 8000g for 2 minutes at 4oC. In the next step, ethanol was removed, and
pellet was washed again with 500µl of 75% Ethanol. In the penultimate step, residual
ethanol sticking to tube walls were removed by flash spinning tubes on a benchtop
centrifuge. Lastly, total RNA was eluted from pellet, by adding 10-40µl of RNase free
water. RNA concentration was measured by NanoDrop (ThermoScientific) adjusted
appropriately and stored at -80oC until use.
Cultured cells (in-vitro):
For isolating total RNA from cells growing in culture, 1ml of Isogen II was added
directly to each well after aspirating out culture media and performing two PB washes.
Scarping of cells was not required as pipetting the lysate 3-4 times into the well ensured
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cell lysis. Lysates were collected in 1.5ml Eppendorf tubes. Thereafter, similar steps for
RNA isolation and quantification were performed as mentioned in the previous section
for mouse embryos.
qRT-PCR analysis:
For accessing mRNA expression levels via quantitative real-time PCR analysis, mRNA
was first converted into complementary DNA (cDNA). SuperScript III First-strand
synthesis (Invitrogen) protocol was used for this purpose. The following mix was pre-
pared in 8-strip PCR tubes and incubated at 65oC for 5 minutes, followed by incubation
ice for 5 minutes.
Sl. No Particulars Volume
1 Total RNA (500ng to 1µg) ≈ 1-2µl
2 2.5 mM dNTP 1µl
3 oligo(dT) 12-18 primer 1µl
4 MQ water ≈ 6-7µl
Total (Mixture 1) 10µl
Thereafter, the following mix (Mixture 2) was added to Mixture 1.
Sl. No Particulars Volume
1 5x First Strand Buffer 4µl
2 RNaseOut 0.5µl
3 SuperScript III RTase 1µl
4 MQ water 4.5µl
Total (Mixture 2) 10µl
Thereafter, tubes were incubated in a thermocycler at 42oC for 1 hour (reverse
transcription), followed by 70oC for 15 minutes (enzyme denaturation). Samples were
diluted 1:10 fold in RNase free water and stored at -20oC until use. For qRT-PCR
reaction, the following components were added in respective amounts:
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Sl. No Particulars Volume
1 cDNA (1:10 dilution) 2µl
2 SYBR Premix ExTaq (Takara) 5µl
3 10µM FP 0.2µl
4 10µM RP 0.2µl
5 ROX reference dye II 0.2µl
6 RNase free water 2.4µl
Total 10µl
Samples were run in three technical replicates using the following PCR conditions:
PCR cycles
Initial Denaturation 95oC 30 sec
Denaturation 95oC 5 sec ×40 cycles
Annealing and Extension 60oC 30 sec
95oC 15 sec
Melting Curve analysis 60oC 60 sec
95oC 15 sec
Data was analyzed using Viia7 sequence detection system (Applied Biosystems)
and exported in MS Excel format. In a given sample, relative mRNA expression of
a target was determined by normalizing with Gapdh expression using ∆∆Ct method
(Livak and Schmittgen, 2001).
2.2.8 RNA Sequencing analysis
High-quality total RNA (500ng) was isolated from pooled E8.0-E8.5 stage embryos
using Isogen II reagent as mentioned in Section 2.2.7 and subjected to RNA-seq library
preparation using TruSeq Stranded mRNA LT Sample Prep Kit (Illumina) based on
manufacturer's protocol. Paired-end RNA sequencing (109 base-pair) was done with
Hiseq PE Rapid Cluster Kit v2-HS and Hiseq Rapid SBS Kit v2-HS (200 Cycle) on
Hiseq2500 (Illumina) machine, following manufacturer's protocol. Assistance in library
preparation and sequencing was provided by Sequencing Center, OIST. Sequencing
reads were mapped to mouse reference genome provided in Ensembl database using
StrandNGS software (Strand Life Sciences). Data analysis was done by mapping reads
to mm10 genome sequence (Ensembl), thereby converting raw counts to corresponding
FPKM scores. For downstream analysis, only protein-coding genes with FPKM scores
≥ 0.05 were selected. Gene set enrichment analysis (GSEA) was performed using online
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software that uses the Molecular Signatures Database (MSigDB) from Broad Institute,
USA.
2.2.9 Nuclear-Cytoplasmic Fractionation
Nuclear and cytoplasmic fractions were isolated using the NE-PER kit (ThermoScien-
tific) according to the manufacturer's protocol. Briefly, pooled embryos samples were
homogenized by pipetting back and forth gently 10 times using P200 tip on ice. Cells
were thoroughly washed 2 times, pelleted down at 500g for 3 minutes, and finally resus-
pended in 100µl of ice-cold 1X PBS. Cell counting was done using Bio-Rad automated
cell counter device. Upon pooling 8-10 WT embryos, a total of 5x108 cells were recov-
ered. Cytoplasmic lysis was done using 200µl of CER I solution followed by 11µl of
CER II solution based on protocol described in kit. Nuclear protein was extracted in
100µl of NER solution. The kit manufacturer recommends the aforementioned volumes
of of CER I, II and NER buffers to fractionate 2× 106 HeLa cells. However, due to the
fragile nature of embryonic cells, and estimates from standardization trials, we chose
to use approximately 25 times more cells for the same about of reagents
2.2.10 Tissue histology and staining
E8.5 and E9.5 stage placental tissues were isolated from individual embryo horns and
fixed in 4% PFA solution overnight. With the help of spatula fixed tissues were gently
transferred into paraffin embedding cassettes duly label with a pencil. Tissues were
washed by immersing cassettes in 1X PBS solution for a total of 30 minutes, with
replacement of PBS every 10 minutes. Thereafter, tissues were dehydrated every 5
minutes in 30% EtOH, followed by 50% EtOH, 70% EtOH, 90% EtOH, and 100%
EtOH. An additional 100% Ethanol dehydration step was performed to ensure minimal
carryover of PBS into next set of solutions. After ethanol-based dehydration, cassettes
were dipped in EtOH-Methyl benzoate solution (1:1) for 15 mins in RT, followed by
incubation in 100% Methyl benzoate solution, for 3 hours at RT. Thereafter, cassettes
were immersed in Xylene-Methyl benzoate solution (1:1) for 15 mins in RT, followed
by Xylene solution for another 15 mins in RT. An additional Xylene incubation for
15 minutes was performed to ensure minimal carryover of Methyl benzoate solution
into next set of solutions. Cassettes were then dipped in Xylene-Paraffin solution
(1:1) overnight at 65oC. On the following day, cassettes were sequentially transferred
into 3 paraffin solutions, and incubated for 1 hour each. At the end of third paraffin
step, plastic or metallic molds were placed on a 65oC heat block. Molten paraffin was
added to molds until half-filled. Thereafter, cassettes containing tissues were gently
pushed while being immersed inside a glass Petri dish filled with molten paraffin.
Using a plastic dropper tissue samples were gently picked and placed inside molds.
While the paraffin remained in molten state, sample orientation was adjusted with
a needle. Once adjusted, paraffin molds were placed on benchtop for 5-10 minutes
allowing solidification. Molds were stored at 4oC until sectioned. 8-10µm sections were
generated using Microm HM325 rotary microtome. Sections were collected on MAS
coated glass slides and dried at 42oC for 1 hour. Thereafter, slides were stacked together
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in a slide stand and placed inside a ziplock bag. In such condition slides containing
paraffin sections could be stored at 4oC until use.
Dewaxing and Hematoxylin-Eosin (H-E) staining:
Prior to paraffin dewaxing, ziplock pack sealed slides were placed at RT for 30 minutes
allowing moisture to dry up. Dewaxing was done by dipping slides thrice in Xylene
solution for 4 mins each in RT, followed by rehydration via serial incubations in 100%
EtOH, 90% EtOH, 70% EtOH, 50% EtOH, 30% EtOH for 2 mins each in RT. There-
after, slides were dipped twice in MQ water for 3 minutes at RT. Hydrated tissue
sections were dipped in Hematoxylin 3G solution (Sakura Finetek, Japan) for 3 min-
utes followed by gentle rinsing in running tap water for 10 minutes. Thereafter, slides
were dipped in MQ water for 30 sec followed by Eosin solution (Sakura Finetek, Japan)
for 3 minutes. Post eosin stain, slides were quickly washed by immersing into MQ water
for 5 seconds, followed by 70% Ethanol for 30 sec, 90% Ethanol for 1 minute, and finally
in 100% Ethanol for another 1 minute. Finally, slides were dehydrated completely by
dipping in 3 successive solutions of Xylene for 2 minutes each, before mounting us-
ing Entellan (Xylene Based mounting medium) or Flourinert. Slides were allowed to
dry for 3-5 hours at RT. Tissue sections were imaged using Keyence BZ-X710 light
microscope.
2.2.11 LacZ staining
Embryos were isolated from pregnant female mice and collected in individual wells of
12-well tissue culture plate filled with 1-2 ml of ice-cold PBS. During dissection, a
small puncture was done with 30G tungsten needle to facilitate entry of fixative and
staining solutions in subsequent steps. E7.5, E8.5 and E9.5 embryos were fixed on ice
fixed using fixative solution (0.2% glutaraldehyde, 2 mM MgCl2, 5 mM EGTA in PBS)
for 5, 10, and 15 minutes respectively. Subsequently, excess fixative was removed by
washing samples three times with 1X PBS for 10 minutes on ice. Thereafter, samples
were rinsed thoroughly with ice-cold rinse buffer (0.01% DOC, 0.02% NP40, 2 mM
MgCl2 in PBS) for 20 min on ice. Finally samples were treated with staining solution
(1mg/ml X-Gal, 0.01% DOC, 0.02% NP40, 5mM K4Fe(CN)6, 5mM K3Fe(CN)6, 2mM
MgCl2 in PBS) and incubated for 48-72 hours at 37
oC, protected from light using foil
wrapping of plate. Reaction mixture should be preheated to 37oC before addition of
X-Gal. Post staining, whole-mount LacZ stained embryos were washed 3 times in 1X
PBS at RT to remove staining solution. Whole-mount staining images were taken
using Keyence BZ-X710 light microscope and thereafter samples were processed for
resin embedding followed by sectioning. Processing of samples began with refixation in
in 4% PFA solution overnight, followed by embedding in JB4 resin (Polysciences, Inc).
Solidified resin blocks were sectioned (8-10µm) using Microtome Rotatif, HM335E.
Sections were dried overnight and imaged. Counterstaining was done by dipping slides
in Eosin for 1-2 seconds followed by immediate washing. Stained sections were dried
at RT, mounted on coverslips using Entellan reagent (Merck Millipore), and imaged
using a microscope.
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2.2.12 Plasmids
Flag-tagged human Cnot9 was cloned into pcDNA3. Cnot9mut4 (H58A, F60A, A64Y,
V71Y) and Cnot9GW182neg (P165G, Y203A, R205A, R244A) constructs were gener-
ated by point mutagenesis. Briefly, primers (tabulated at the end of this section)
incorporating mutations were used to PCR amplify parent plasmid (pcDNA3-Cnot9 )
catalyzed by Phusion polymerase (Invitrogen) following manufacturer's protocol. PCR
reaction mixture was digested by Dpn1 enzyme for 3 hours at 37oC. Post digestion, a
small fraction was run on 1% Agarose gel to confirm PCR product size and quality.
Thereafter, ligation was done using Solution I from DNA ligation kit (Takara) supple-
mented with 0.5µl of T4 Polynucleotide Kinase (10U/µl) and 0.2µl of ATP (100mM)
for 20µl reaction. Ligation was done for 1 hour at 16oC followed by transformation into
competent DH5a strain of E. coli. Transformants were selected on agar plates supple-
mented with antibiotics. Plasmid isolation was done using plasmid miniprep kit from
Qiagen following manufacturer's instructions. Incorporated mutations were confirmed
by restriction digestion and DNA sequencing. Mouse Lefty1 3'-UTR (425 bp), Lefty2
3'-UTR (1290 bp), c-myb 3'-UTR (1243 bp), also cloned into the pGL3 control vector
(Promega) using cDNA library of E7.5 stage mouse embryos. Primers with restric-
tion sites were designed and used for PCR based amplification. PCR products were
digested using restriction enzymes, purified using Qiagen PCR purification kit, and
subsequently ligated using DNA ligation Kit (Takara). Transformation, drug selection
and plasmid preparation were done as mentioned above. Plasmids were confirmed by
restriction digestion and DNA sequencing. p21(cdkn1a) 3'-UTR in pGL3.0 control vec-
tor was generated by Dr. Akinori Takahashi in the laboratory. Flag-tagged full-length
silencing domain of human Tnrc6c (1260-1690 amino acids) was PCR amplified from
RIKEN cDNA library (KIAA1582) and cloned into pcDNA3.0 vector.
Mutant Primers (5' - 3') Restriction
site gen.
Mutation
gen.
Cnot9mut4
ATGCTGTGGGCTTCAGCTGGTACTATT
Pvu II
H58A,
F60A
GGGTGCAAGGTCAGGAACAGATTCT
GGTACCATTTACGCACTTTTACAGG
Kpn I A64Y
AGCTGAAGCCCACAGCATG
GCACTTCTGCAGGAAATTTACAATATTTATCCA
Pst I V71Y
GTAAATGGTACCAGCTGAAGCCCA
Cnot9GW182neg
ATATGTCAGACGGCTGAGGCTTTCTCC
Bgl II
Y203A,
R205A
ATAAGCCAAACCAGTGTCATCTAACAGGATCTTCTG
CTTTCAGATAACCCCGCGGCACGTGAA
Sac II R244A
TCGAAGGTAACATCTCACTACATGCTTCAGCAG
GAAATTATCGGTTTATGTCTACGAATTATG
Acc I P165G
TGTTGTTAATAAAAAGTTGATTACTTCTTGTTC
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2.2.13 Generation of CNOT9 KOHeLa cells using CRISPR/Cas9
technique
Guide RNA sequences were designed using CHOP-CHOP (https://chopchop.cbu.uib.no/),
a web-based interface provided by the University of Bergen, Norway. Insert oligonu-
cleotides targeting exon1 of human Cnot9 were: 5'-CACCGGCACAGCCTGGCGACGGCTG-
3' and 5'-AAACCAGCCGTCGCCAGGCTGTGCC-3'. These complementary oligos
were annealed and cloned into pSpCas9(BB)-2A-Puro vector using the following method
(Ran et al., 2013).
Vector [pSpCas9(BB)-2A-Puro] processing
The following reaction was prepared and incubated at 37oC for 30 minutes.
Sl. No Particulars Volume
1 Vector DNA (1µg/µl) 1µl
2 Bbs1 enzyme (NEB) 1µl
3 10x NEB Buffer 2.1 2µl
4 RNase free water 16µl
Total 20µl
Upon conclusion, 0.5µl of Calf Intestinal Alkaline Phosphatase (CIAP) was added
and incubated for 30 minutes at 50oC to hydrolyze 5' phosphate group. Thereafter,
solution was incubated at 70oC for 10 minutes for CIAP inactivation. Vector DNA was
purified using Qiagen PCR purification kit, eluted in 50µl of MQ water, and stored on
ice until ligation step.
Phosphorylation and annealing of oligo(s)
Oligonucleotide sequences were annealed and phosphorylated in the following manner:
Sl. No Particulars Volume
1 100µM Oligo #1 5µl
2 100µM Oligo #2 5µl
3 10X T4 Polynucleotide Kinase Buffer 2µl
4 100mM ATP 0.2µl
5 T4 Polynucleotide Kinase 0.5µl
6 RNase free water 7.3µl
Total 20µl
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Solution was incubated at 37oC for 30 mins followed by another incubation at 95oC
for 5 minutes. 95oC incubation was done by dropping sealed Eppendorf tube into a
beaker full of boiling water. After 5 minutes, heater was turned off and water was
allowed to cool to RT.
Ligation
Ligation was setup at 16oC for 1 hour by adding reagents in the following manner:
Sl. No Particulars Volume
1 Bbs1 digested plasmid vector 50ng
2 Phosphorylated and annealed oligo 2µl
3 Ligation Solution I 6µl
4 RNase free water ≈1-2 µl
Total ≈10-12µl
5-6µl of ligation mix was used for transformation into competent DH5a strain of E.
coli. The above method is adapted from a previously published protocol (Ran et al.,
2013).
Plasmids were confirmed by DNA sequencing. HeLa cells were transfected us-
ing pSpCas9(BB)-2A-Puro vectors containing guide RNAs that target Cnot9 genomic
locus. As a guideRNA control, pSpCas9(BB)-2A-Puro vector targeting a region of
EGFP gene was used. 24 hours post transfection, cells were treated with 2.5 µg/ml
of puromycin for 3 days to select transfected cells. After 3 days, cells were collected,
and seeded in three 10 cm culture dishes at a density of 300 cells per dish. Media
was changed every 2 days. After 10-12 days of culture, small colonies were picked and
seeded into individual wells of a 48 well plate and propagated further. Knockout clones
were confirmed by DNA sequencing and Western blotting.
2.2.14 Lentiviral delivery of CNOT9 into placental lineage for
rescue experiment
Mouse Cnot9 coding sequence was amplified from E9.5 embryo cDNA library and
cloned into pLV-CAG1.1 vector (kindly provided by Dr. Masahito Ikawa, Osaka
University) at BamH1 and Xho1 restriction sites. Control lentivirus pLV-CAG1.1-
EGFP along with packaging plasmids pMDLg/pRRE, pRSV-Rev, and pVSVG were
also kindly provided by Dr. Masahito Ikawa. Virus particles were produced in culture
supernatants of HEK293T cells transfected with lentiviral plasmids. Supernatant was
enriched by ultracentrifugation and virus concentration was determined by ELISA for
p24 protein using RETROtek Zeptometrix kit. 2µl aliquots of virus particles were
prepared and stored at -80oC until use.
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For obtaining blastocysts, ≈28-day old females were super-ovulated by intraperi-
toneal injection of 7.5U pregnant mare serum gonadotropin (PMSG), followed by ad-
ministration of 7.5U of human chorionic gonadotropin (HCG) after 47hours. Post HCG
injection, mice were paired with stud males. Plug positive female mice were used for
isolation of E2.5 stage (morula) embryos by flushing oviducts with M2 culture media
supplemented with antibiotics. E2.5 embryos were cultured in-vitro in KSOM media
for approximately 24 hours allowing them to form blastocysts. Prior to virus transduc-
tion, zona pellucida were removed by treatment with acidic Tyrode solution (Sigma).
Equal number of zona-removed blastocysts were transduced by CNOT9 and EGFP ex-
pressing virus for 4 hours at 37oC. Thereafter, embryos were transplanted into 2.5-day
pseudo-pregnant ICR female mice for further development. Approximately 6-7 days
later pregnant ICR females were euthanized and lentivirus transduced placenta were
examined for biochemical analysis.
2.2.15 Statistical analysis
Unpaired, two-tailed Student's t-test was used for data analysis. Bar graphs repre-
sented Mean ± standard deviation (SD) and p-values < 0.05 were deemed statistically
significant.
2.3 Results
2.3.1 Loss of CNOT9 causes defects in embryonic gastrulation
Generation of Cnot9+/lacZ mice has previously been described in Materials and Methods
(Section 2.2.1). Loss of one Cnot9 allele showed no detectable phenotype under normal
breeding conditions compared to wild-type controls. However, upon crossing male and
female Cnot9+/lacZ mice, no Cnot9 lacZ/lacZ (KO) mice were born. Furthermore, no KO
embryos could be genotyped at E14.5, suggesting early embryonic lethality resulting
from loss of CNOT9. To identify the timing of embryonic lethality and onset of pheno-
typic defect in KO embryos, we investigated gastrulation stage embryos, 7 to 10 days
post coitum. As seen in Fig. 2.2A and Fig. 2.2B, no obvious differences in KO embryo
morphology were observed during early Bud/Headfold stages (E7.25 - E7.75) and early
somite stages (E7.75 - E8.0), compared to littermate controls. Onset of phenotypic de-
fects occurred during intermediate and late somite stages (E8.0 - E8.5) as KO embryos
showed growth retardation in regions of the developing embryo-proper (Fig. 2.2C).
During E9.5 stage of development, KO embryos exhibited more severe growth de-
fects characterized by small size, perturbed developmental pace indicated by delay in
embryo curling, and lack of blood vessels within visceral yolk-sac regions (Fig. 2.2D).
Contrary to previous stage of development, KO embryos exhibited higher cleaved PARP
expression compared to WT littermates, suggesting cell death within these embryos
(Fig. 2.2D). At E10.5 stage of embryonic development, KO embryos continued to dis-
play defects in terms of embryo size and morphology and showed sustained increase in
cleaved PARP expression compared to WT littermate controls (Fig. 2.2E). Genotype
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Figure 2.2: Phenotype of CNOT9 KO and Sox2-Cre cKO embryos Embryo
morphology and size evaluation of CNOT9 KO embryos alongside WT controls during
(A) Bud and Headfold stages (E7.25  E7.75) (B) Early somite stages (E7.75  E8.0)
(C) Intermediate to Late Somite stages (E8.0  E8.5) (D) and (E) Late gastrulation
stages (E9.0  E10.5). Western Blotting for PARP (lower band) indicates extent of
tissue death in KO or cKO embryos compared to WT control. Scale: 500µm
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of KO embryos were confirmed both by PCR based genotyping and western blotting.
2.3.2 CNOT9 KO embryo phenotype primarily contributed by
epiblast lineage
Defects originating in placental lineage (trophectoderm derived cells) during stages of
embryonic gastrulation and thereafter, can have a profound effect on development and
viability of embryos (Perez-Garcia et al., 2018). We therefore performed histological
analysis on placental regions during E8.5 and E9.5 stages and found that KO embryos
possessed significantly smaller sized placenta compared to WT and HE littermate con-
trols (Fig. 2.3A, 2.3B).
Figure 2.3: Placenta in E8.5 and E9.5 stage CNOT9 KO embryos (A) Placen-
tal morphology at E8.5 and E9.5 stages examined by H-E staining of paraffin embedded
tissue (B) Quantification of placenta size in CNOT9 KO embryos compared to HE and
WT controls (Statistical significance indicated by * p<0.05, ** p<0.01, *** p<0.001,
values are Mean ± SD, n=3) (C) Schematic representation of placental lamination
during E8.5-E9.5 stage. Scale: 250µm.
For the purpose of visual ease, the relevant region of placenta lies within yellow
broken lines (Fig. 2.3A). Furthermore, a schematic representation of placental layers
during this developmental stage is shown in Fig. 2.3C. A reduced or poorly developed
placenta may however be caused due to an overall impairment in embryo development
and differentiation. To test this observation from the standpoint of direct vs. indi-
rect outcome of CNOT9 loss, we performed experiments using Cnot9 flox/flox mice, as
described in Materials and Methods (Section 2.2.1). Cnot9 flox/flox mice were crossed
with Sox2-Cre mice (B6.Cg-Edil3Tg(Sox2-cre)1Amc/J, Jackson Labs, USA) to gener-
ate epiblast specific knockout (cKO) mice. Similar to KO mice, no cKO mice were born
suggesting embryonic lethality. A total of 32 neonate mice (across 5 batches of litters)
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were sampled, yet no cKO mice could be genotyped (Table 2.2). Analysis of gastrulat-
ing cKO embryos during intermediate and late somite stages indicated no characteristic
morphological differences between WT controls (Fig. 2.2C). However, during late gas-
trulation stages, defects in cKO embryos began to surface, initially in terms of yolk-sac
vasculature, followed by growth arrest and cell death in embryo-proper (Fig. 2.2C and
2.2D).
Genotype Observed mice number Expected mice number*
Cnot9 flox/+; +/+ (WT) 13 8
Cnot9 flox/−; +/+ (HE) 6 8
Cnot9+/−; Cre/+ (HE) 13 8
Cnot9−/−; Cre/+ (cKO) 0 8
Total 32 32
Table 2.2: Genotype assessment of CNOT9 cKO mice Genotype frequency
of 3-week-old mice across 5 independent litter sets generated from crosses between
Cnot9 flox/flox females and Cnot9 flox/+ Sox2-Cre males. *: Expected Mendelian fre-
quency in case of complete rescue of phenotype.
2.3.3 Overexpression of CNOT9 in placental lineage leads to
embryonic lethality
Trophoblast specific lentivirus based gene delivery has been successfully shown to com-
plement placental defects and in some cases embryonic lethality of knockout mice
(Okada et al., 2007). Prior to usage of Sox2-Cre mediated conditional depletion of
CNOT9, we tested lentiviral transduction of Cnot9 into trophectoderm lineage in an
attempt to rescue KO embryo phenotype. A detailed description of plasmid construc-
tion and virus generation is discussed in Materials and Methods section. As shown in
Figure 2.4A, we observed very precise expression of EGFP, exclusively within placen-
tal regions of embryos timed to E9.5 stage of embryonic development. Virus induced
expression of CNOT9 and EGFP was confirmed by western blotting and qRT-PCR
based analysis of placental tissue lysates as shown in Figure 2.4B and Figure 2.4C,
respectively. For the purpose of surrogacy, 4 ICR dams were transplanted with 28
blastocysts each (14 blastocysts transduced by pLV-EGFP and other 14 transduced by
pLV-CNOT9). Based on experiment summary indicated in Table 2.3, more than 90%
(10/11] of pLV-mCNOT9 transduced blastocysts did not have any adjoining embryo-
proper tissue. This suggests that overexpression of CNOT9 within trophoblast lineage
is likely to affect differentiation of embryo proper. This result was also supported by
biochemical evidence of elevated p53 protein levels in CNOT9 transduced placenta
compared to EGFP transduced controls (Figure 2.4D). Further investigation needs to
be done to confirm this observation.
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Figure 2.4: Gene targeting strategies adopted for generation of transgenic
mice (A) LacZ knock-in mouse by targeting exon1 of Cnot9 genomic locus (B) CNOT9
conditional mouse by targeting exons 2 and 3 of Cnot9 genomic locus.
Dam
no.
Embryos
Implanted
E9.5 embryo
condition
E9.5 placenta
condition
Remarks
1 - - - Dead on following day
2 0 - - No embryos implanted
3 2 Normal EGFP +ve pLV-EGFP transduced
4 12 Nonexistent EGFP -ve pLV-CNOT9 transduced
Nonexistent EGFP -ve pLV-CNOT9 transduced
Very small EGFP -ve pLV-CNOT9 transduced
Nonexistent EGFP -ve pLV-CNOT9 transduced
Normal EGFP -ve pLV-CNOT9 transduced
Nonexistent EGFP -ve pLV-CNOT9 transduced
Nonexistent EGFP -ve pLV-CNOT9 transduced
Very small EGFP -ve pLV-CNOT9 transduced
Normal EGFP +ve pLV-EGFP transduced
1 embryo only EGFP+ve,
EGFP-ve
Two fused placentae
Very small EGFP -ve pLV-CNOT9 transduced
Normal EGFP +ve pLV-EGFP transduced
Nonexistent EGFP -ve Two fused placentae
Table 2.3: Placental CNOT9 overexpression leads to loss of embryo proper.
Summary of phenotypes observed in E8.5E9.5 stage embryos developed from blasto-
cysts transduced by pLV-EGFP and pLV-CNOT9 viruses
2.3 Results 33
2.3.4 Cnot9 expression pattern during embryonic gastrulation
Cnot9+/lacZ embryos between E7.5 to E9.5 stages were used to perform β-galactosidase
(β-gal) staining indicative of spatiotemporal expression pattern of Cnot9 (Figure 2.5).
Figure 2.5: spatiotemporal expression pattern of Cnot9 during gastrula-
tion LacZ staining of Cnot9+/lacZ embryos at (A) E7.5 (B) E8.5 (C) E9.5 stages of
gastrulation. (D) Schematic representation of various cell types in E8.5- E9.5 pla-
centa. (E) Mean Cnot9 mRNA expression levels, relative to Gapdh, in various embryo
regions. Scale: 250µm, Ext-Em: extra embryonic, EPC: Ectoplacental cone, EP:
Embryo-proper, PL: Placenta, YS: Yolk-sac, A: Anterior end, P: Posterior end, Pr.:
Proximal end, D: Distal end.
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At E7.5 stage, β-gal staining was predominantly seen within the epiblast region
that would eventually contribute to form the embryo-proper (Figure 2.5A). At 8.5
stage, β-gal staining was seen in various parts of the embryo-proper that included
neuroepithelium, the trunk region, and the caudal region of embryo. More importantly,
β-gal staining was also seen in extra-embryonic yolk-sac and within the ectoplacental
cone (EPC) region of the embryo (Figure 2.5B). A day later, E9.5 stage embryos showed
strong β-gal staining within labyrinthine and spongiotrophoblast regions of the placenta
relative to weak and punctuated signal from regions of the embryo-proper (Figure
2.5C). A schematic representation of placental layers during E9.5 stage is depicted for
visualization of lacZ expression within the placenta (Figure 2.5D). In addition to lacZ
staining, Cnot9 mRNA expression (relative to Gapdh) at various regions of gastrulating
WT embryos, was determined by qRT-PCR analysis (Figure 2.5E). In agreement with
β-gal staining pattern, Cnot9 expression was found to be approximately > 1.5 higher
in E9.5 placenta compared to embryo-proper. Besides E9.5 stage, other stages of
gastrulation, showed nearly uniform expression levels of Cnot9 mRNA.
2.3.5 Gene expression in gastrulating embryos regulated by
CNOT9
Phenotype observed upon in KO gastrulating embryos served as a framework for in-
vestigating gene expression control mediated by CNOT9. In an attempt to investigate
molecular function of CNOT9, we performed RNA-Sequencing analysis of three inde-
pendent E8.0-E8.5 stage WT and KO samples. From a total of 15534 candidates, only
384 protein coding genes were upregulated >2-fold, while another 338 were downregu-
lated >2-fold in KO embryos.
Figure 2.6: Number of upregulated and downregulated targets in KO em-
bryos identified by RNA-Seq Dot-plots representing (A) overall gene expression pat-
tern in WT and KO embryos. (B) more than 2-fold upregulated and downregulated
targets.
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Figure 2.7: Top 50 upregulated and downregulated targets of CNOT9 in
embryos Heat-map indicating top 50 upregulated (left) and downregulated (right)
targets in three independent sets of WT and KO embryos. Values are Log2RPKM ±
SD [n=3]
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This statistic is based on normalized RPKM scores (Figure 2.6A and 2.6B). Top
few upregulated targets include: Lefty2, Lefty1, Nodal, Crypto-1, and Noto that have
previously been known to play profound roles in embryonic gastrulation (Meno et al.,
1996, Meno et al., 1998, Saijoh et al., 1999, Lowe et al., 2001). Top 50 of these targets
have been represented in the form of a heatmap in Figure 2.7. In-silico results were
further validated by qRT-PCR based analysis using cDNA samples obtained from E8.5
stage WT and KO embryos (Figure 2.8A). With the exception of Noto, other targets
that showed upregulation at E8.5 stage, also showed either a trend or a significant
increase during E7.5 stage. This suggests that despite the lack of phenotypic defects
during E7.5 stage, molecular events leading to abnormal embryo phenotype has already
perpetuated within KO embryos. In addition to validation of individual targets, we
also performed pathway analysis using gene-set enrichment analysis (GSEA) algorithm
made available by the Broad Institute, USA. GSEA clearly identified Nodal and TGF-
β signaling pathways to be affected in KO embryos, thereby summarizing the nature
of gastrulation defects (Figure 2.8B). In addition to upregulated targets involved in
gastrulation, E8.5 stage KO embryos also showed higher expression for Oct4 and c-
myb mRNAs (Figure 2.8A).
Figure 2.8: Validation of upregulated targets and pathway identification (A)
Relative mRNA expression levels of upregulated targets in E7.5 and E8.5 stage KO
embryos for (left) gastrulation targets (right) additional targets involved in embryo
development. Values are Mean ± SD [n=5, p < 0.05 (*), p < 0.01 (**), p < 0,001
(***)] Grey and black bars indicate comparison between WT and KO embryos at
stages E7.5 and E8.5, respectively. (B) List of top upregulated pathways in CNOT9
KO embryos mainly involved in TGF-β signaling pathways influenced by Nodal and
other competing ligands.
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Downregulated targets mainly suggested retarded embryo growth and differentia-
tion characterized by significantly reduced expression levels of Myl2, Epo, Fgf8, Sox10
and Pax family members - Pax1, Pax5 and Pax7 (Figure 2.9). Top 50 downregulated
targets have been represented as a heatmap in Fig. 2.7. Upon performing GSEA,
downregulated targets did not clearly correspond to any specific signaling pathway
(data not shown). A list of different primers used for qRT-PCR analysis has been
listed in Table 2.4.
Figure 2.9: Validation of downregulated targets in KO embryos Relative
mRNA expression levels of downregulated targets in E8.5 KO embryos. Values are
Mean ± SD [n=5, p < 0.05 (*), p < 0.01 (**), p < 0,001 (***)]
Sl. No Target Forward Primer (5'-3') Reverse Primer (5'-3')
1 Lefty1 actcagtatgtggccctgcta aacctgcctgccacctct
2 Lefty2 gccctcatcgactctaggc agctgctgccagaagttcac
3 Noto tgtttgcaaagcagcacaa ttggaaccagatcctcacct
4 Cfc1 tgtgttctgggcagtttctg cctagggcaccacagtct
5 Nodal tggtagggaagacccacaac tgccaagcatacatctcagg
6 c-myb cctcaaagcctttaccgtacc ctgtcttcccacaggatgc
7 Oct4 aagttggcgtggagactttg tctgagttgctttccactcg
Table 2.4: List of primers used for qRT-PCR based analysis
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2.3.6 CNOT9 is core component of CCR4-NOT complex in gas-
trulating embryos
Before accessing the role of CNOT9 in mediating target mRNA decay, we wished
to confirm its presence within the CCR4-NOT complex in gastrulating embryos. As
shown in Figure 2.10, CNOT9 was immunoprecipitated (IP'd) by anti-CNOT3 anti-
body alongside other CCR4-NOT subunits such as CNOT1 and CNOT2, compared
to Control IgG. Furthermore, GW182, a component of the miRNA-RISC complex was
also IPed, implying interactions between the CCR4-NOT complex and the RISC com-
plex in inducing miRNA mediated decay of target mRNA. 4EBP1 and a-tubulin served
as controls for this assay.
Figure 2.10: CNOT9 is part of the CCR4-NOT complex during gastrulation.
Co-IP assay with anti-CNOT3 antibody on mouse embryo lysates IP'd CNOT9 and
GW182.
2.3.7 Subcellular localization of CNOT9 in gastrulating em-
bryos:
To examine subcellular localization of CNOT9 during gastrulation, we performed nuclear-
cytoplasmic fractionation using E8.0 to E8.5 embryo lysates. As shown in Figure 2.11,
majority of CNOT9 protein is localized within cytoplasmic fraction, likely to be bound
to the CCR4-NOT complex. XRN1 protein is a well-known shuttling molecule and
is therefore seen in both nuclear and cytoplasmic fractions with appreciable degree of
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abundance. Histone H3 was used as control for nuclear fraction while Tubulin was used
as cytosolic fraction control.
Figure 2.11: Nuclear-Cytoplasmic fractionation of E8.0-E8.5 stage embryos
2.3.8 CNOT9 contributes to Lefty1/2 mRNA decay, in-vitro:
With the understanding of CNOT9 being a part of the cytoplasmic mRNA decay com-
plex we hypothesized its function in facilitating decay of its targets. To investigate
the role of CNOT9 in the context of mRNA decay, we pursued two candidate targets
- Lefty1 and Lefty2, as identified and validated in Section 2.3.5. One of the main rea-
sons for picking these targets among others, is the presence of miRNA binding sites
within respective 3'UTR elements that may facilitate mRNA decay, in-cis. Based on
information available from TargetScan mouse database, a schematic representation of
microRNA binding loci within 3'UTR of Lefty1, Lefty2,and c-myb mRNA is shown
in Figure 2.12. We found that addition of these 3'UTR elements downstream of lu-
ciferase coding element, led to a significant reduction in luciferase activity relative to
vector-only (pGL3.0) control (Figure 2.13). Furthermore, with the exception of Lefty1
3'UTR, luciferase transcripts conjugated with 3'UTR elements also saw a significant
reduction in mRNA expression levels relative to vector-only controls (Figure 2.13).
In the next step, we investigated the role of CNOT9 in facilitating mRNA decay
of luciferase reporters conjugated with individual 3'UTR elements. As seen from Fig.
2.14A, mRNA decay kinetics determined by ActinomycinD chase assay showed a clear
stabilization of Lefty2 3'UTR conjugated reporter mRNA, whereas in the case of Lefty1
3'UTR, the stabilization was minimal. As expected, c-myb 3'UTR known to possess
multiple microRNA binding sites, showed clear impairment in reporter mRNA decay
in absence of CNOT9 (Figure 2.14A). p21(cdkn1a) 3'UTR conjugated reporter, used
as a negative control, did not show any significant difference in decay kinetics (Figure
2.14A).
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Figure 2.12: microRNA binding sites within 3'UTR elements of Lefty1/2
and c-myb Schematic representation of 3'UTR elements for Lefty1, Lefty2 and c-myb
mRNA with positions of microRNA binding sites
Figure 2.13: Reporter luciferase assay to study contribution of cloned
3'UTR element Luciferase activity (left) and mRNA expression (right) in cells trans-
fected with Lefty1 (L1), Lefty2 (L2), or c-myb 3'UTR elements relative to control.
Values are Mean ± SD [n=3, p < 0.05 (*), p < 0.01 (**), p < 0,001 (***)]
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Figure 2.14: Decay kinetics of Luciferase reporter conjugated with 3'UTR
elements (A) of Lefty1, Lefty2, and c-myb (B) of p21 3'UTR as non-target control and
Fhl3 as endogenous control. Blue dots represent relative expression of reporter mRNA
in CNOT9 KO cells reconstituted with human CNOT9, whereas black dots represent
expression in CNOT9 KO cells reconstituted with mutant CNOT9 (CNOT9mut4) that
cannot interact with CNOT1. (C) Western Blotting suing anti-CNOT9 and anti-FLAG
antibodies to ensure equal expression of CNOT9 and CNOT9mut4 proteins. Values are
Mean ± SD [n=3, p < 0.05 (*), p < 0.01 (**)]
Similar decay kinetics for Fhl3 mRNA (endogenous control) under different treat-
ment conditions, implied uniform dose-response to ActinomycinD treatment (Figure
2.14B). Western blotting using anti-CNOT9 and anti-FLAG antibodies, confirmed
equal extent of expression for wildtype and mutant forms of CNOT9 across different
treatments (Figure 2.14C).
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2.4 Discussion
The mammalian CCR4-NOT complex is profoundly involved in regulation of gene ex-
pression during early embryonic development. In this study we highlighted the phys-
iological role of subunit CNOT9 in during embryonic gastrulation. CNOT9 knockout
mice exhibited developmental abnormalities during mid-gastrulation stages (E8.0 to
E8.5) leading to embryonic lethality at E9.5 stage. KO embryos showed a spectrum of
defects that included reduced size, arrested growth, and pale colorization of embryo-
proper, impaired yolk-sac vasculature, and significantly reduced placenta. Chorioal-
lantoic fusion defects were not observed in E8.5 KO embryos (data not shown). To
determine the weightage contribution of epiblast vs. trophoblast derived cells, we ex-
amined phenotype of embryos that underwent epiblast specific depletion of CNOT9.
A marginal delay in onset of phenotype and timing of embryo lethality was observed
in Sox2-Cre conditional knockout mice, suggesting that phenotypic defects in KO em-
bryos were mainly contributed by cells originating from the epiblast lineage. In other
words, wildtype trophoblast lineage cells could not adequately rescue the phenotype
observed in whole body knockouts. As a first step towards examining function, we
investigated embryo-wide expression pattern of Cnot9 using whole-mount LacZ stain-
ing and qRT-PCR based analysis. During onset of gastrulation (≈E7.5), Cnot9 was
almost exclusively expressed throughout the epiblast. However, late in gastrulation,
(E8.5 to E9.5) expression was also seen within extra-embryonic regions including re-
gions of the developing placenta. It is worth noting that both E8.5 and E9.5 placental
regions showed higher expression of Cnot9 compared to relative levels within adjoining
embryo proper. Unfortunately, due to timing and nature of defects, both KO and con-
ditional knockout mice models limit our understanding of CNOT9 within a functional
placenta. It would be worth investigating CNOT9 function within placental lineage
via in-vitro trophoblast stem cell-based differentiation assays, or in-vivo models that
can induce placenta specific depletion.
Prior to assessment of lineage contribution (trophoblast vs. epiblast) using Sox2-Cre
mice model, we had attempted an alternate rescue approach involving lentivirus-based
complementation (Okada et al., 2007). During standardization of this method, we made
a serendipitous observation. CNOT9 overexpression specifically in trophoblast derived
cells strongly correlated to non-viable development of adjoining embryo-proper, com-
pared to EGFP overexpression controls. This suggests that, overexpression of CNOT9
also has phenotypic consequences on embryo development possibly due to aberrant
activity of the CCR4-NOT complex. Further investigation in this direction shall offer
a definitive molecular understanding on CNOT9 overexpression.
Phenotypic defects in KO embryos served as a template for investigating molecular
function of CNOT9. E8.0 to E8.5 staged WT and KO embryos were pooled and sub-
jected to bulk RNA Sequencing analysis. With biochemical validation, we observed
significant upregulation in mRNA levels of Lefty1/2, Nodal, Cfc-1, among others that
have previously been shown to have profound roles in embryonic development (Con-
lon et al., 1994, Meno et al., 1998, Meno et al., 1999, Yan et al., 1999).For instance,
overexpression of Lefty2 in zebrafish embryos blocks head and trunk mesoderm forma-
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tion (Meno et al., 1999). Cfc-1 overexpression in mice caused downregulation of genes
involved in cardiac differentiation starting mid gastrulation stages whereas in chick,
its gain-of-function led to suppression of posterior mesodermal fates while promoting
anterior mesoderm development (Chu et al., 2005, Lin et al., 2016). Nodal overexpres-
sion has been shown to promote differentiation of mouse ES cells into endoderm and
mesoderm lineages at the expense of neuroectoderm formation (Pfendler et al., 2005).
Despite these findings, very little is known from the standpoint of post-transcriptional
regulation of such transcripts and their consequences on embryo development. Having
said that, one report showed Lefty2 regulation via microRNA-127 in mouse ES cells
(Ma et al., 2016). We therefore present a model where upregulation of gastrulation
related transcripts can be studied with physiological relevance.
We focused on Lefty1 and Lefty2 transcripts mainly because of the extent of up-
regulation and presence of canonical microRNA binding sites in their 3'UTR elements.
With the help of TargetScan database, we found that both mRNAs contain an AAG-
CACU element that serves as binding sites for miR-291-3p, miR-294-3p, miR-295-3p,
miR-302-3p microRNA. We therefore cloned 3'UTR elements in pGL3.0 luciferase ex-
pression vectors. In WT HeLa cells, relative to vector only control, luciferase reporter
expression and activity was significantly reduced when conjugated with Lefty1 and
Lefty2 3'UTRs. We further clarified that, in presence of human CNOT9 that cannot
interact with the CCR4-NOT complex (Cnot9mut4), mRNA decay of reporters contain-
ing Lefty1 or Lefty2 3'UTRs was significantly compromised. Due to very high sequence
conservation of human vs. mouse CNOT9 proteins (99.7%), and microRNA binding
sites within UTR elements of mouse and human Lefty transcripts, we believe that a
similar mechanism is likely to be present in humans.
Pale color of E8.5 - E9.5 stage KO embryos can be explained in terms of dysfunc-
tional waves of primitive and definitive waves of erythropoiesis depending on c-myb
expression. Downregulation of c-myb transcription has previously been reported to
be imperative for erythropoietin (epo) induced differentiation (Todokoro et al., 1988).
Furthermore, retinoic acid has been shown to suppress c-myb expression (Mandelbaum
et al., 2018). CNOT9 is believed to be a retinoic acid inducible and therefore, in agree-
ment with these ideas, our data suggests a strong correlation in terms of loss of CNOT9,
elevation of c-myb expression, and reduced Epo expression (Hiroi et al., 2002).The dif-
ference however lies in the manner in which c-myb mRNA expression is elevated. The
previous two evidences showed transcriptional control in c-myb expression, while our
data suggests post-transcriptional control (via mRNA stabilization) in the backdrop
of CNOT9 loss. Although defects in blood formation may be triggered by improper
germ layer differentiation at earlier stages of gastrulation, we believe that elevation
of c-myb mRNA can inhibit EPO induced erythroid differentiation in CNOT9 KO or
conditional knockout mice. Further analysis using mice models for erythroid specific
deletion can help elucidate this aspect of CNOT9 function.
CNOT9 KO embryos also show increased expression of Oct4 mRNA. To understand
such increase from the standpoint of mRNA decay, we cloned its 3'UTR element from
E6.5 cDNA library. However, no effect of 3'UTR element was seen on reporter mRNA
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expression levels in WT HeLa cells. Although we cannot provide an exact mechanism
in support of its increase, we speculate that may be indirectly contributed by higher
abundance of cells in undifferentiated state within KO embryos, compared to controls.
CNOT9 has regulatory roles within the complex that assist mRNA decay processes
by interacting with CNOT1 and stimulating catalysis via CNOT6/6L and CNOT7/8
(Pavanello et al., 2018). This idea was further perpetuated by an in-vitro study of the
human CCR4-NOT complex, that suggested stimulus dependent CNOT9 interaction
with RBPs resulting in targeted mRNA decay (Raisch et al., 2019). In congruity
with this idea we observed a similar trend in our RNA-Seq data. Only 722 (less than
5%) out of 15534 total detected protein coding genes underwent more than 2-fold
significant change suggesting that developmental stimulus controls expression of very
specific targets via CNOT9, leaving a fraction of them unaffected.
Chapter 3
Molecular interactions of mammalian
CNOT9 protein
3.1 Motivation
This chapter revisits the current molecular model that supports CNOT9 as a cata-
lyst in mediating interactions between CNOT1 and TNRC6 (GW182) family of pro-
teins, thereby promoting microRNA mediated translation suppression and mRNA de-
cay (Fabian et al., 2011, Huntzinger et al., 2013, Chen et al., 2014, Mathys et al., 2014).
Key highlights of these studies relevant for our research have been tabulated in Table 3.1
Although the above concepts are well supported by crystal structure analysis and
biochemical evidence, a few questions pertaining to protein-protein interactions remain
unaddressed. The following two observations from previous studies prompted us to
readdress this topic:
1 Mutant CNOT1 K1426S, G1451Y, R1458A, Q1549A and
CNOT1 K1426S, G1451Y, R1458A,Q1549A, I1423D that cannot bind CNOT9, interacted
with SD of TNRC6 proteins with comparable affinity relative to wild-type CNOT1
protein (Chen et al., 2014). This contradicts the idea that interaction of TNRC6s
with CNOT1 predominantly occurs at the DUF3819 domain that is bound to
CNOT9 (Huntzinger et al., 2013, Chen et al., 2014).
2 CNOT9 was shown to interact with SD of TNRC6 proteins only when bound to
CNOT1 (Chen et al., 2014). This was supported by lack of interactions between
CNOT9 H58A, F60A, A64Y, V 71Y (CNOT1 binding mutant) and SD of TNRC6, in
HEK293T cells (Chen et al., 2014). However, another study performed in the
same cell line, claimed possibility of direct interactions between CNOT9 and a
fragment of TNRC6 SD, dependent on hydrophobic interactions between trypto-
phan binding pockets on CNOT9 and tryptophan(W) residues on TNRC6 pro-
tein (Mathys et al., 2014). Neither studies clearly account for contribution from
endogenously expressed proteins (CNOT1 and CNOT9) that can potentially in-
fluence their claims.
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Sl.
No.
Observation/Result/Claim Reference Method/Data
1 TNRC6 proteins interact with CNOT1
at more than one locus, DUF3819 do-
main being the major site
(Huntzinger et
al., 2013)
Co-IP assay [Fig 9A]
2 DUF3819 domain of CNOT1 also inter-
acts with CNOT9
(Chen et al.,
2014)
[Fig 1B, 1C]
3 DUF3819-CNOT9 binary complex is
the major interaction site for the
TNRC6 silencing domain (SD)
(Chen et al.,
2014)
Co-IP assay, [Fig 1E]
4 CNOT9 homodimerization and inter-
action with CNOT1 (via DUF3819) in
mutually exclusive
(Chen et al.,
2014)
CNOT1-CNOT9 is
stable helix-helix hy-
drophobic interaction
5 CNOT9 (H58A, F60A, A64Y, V71Y)
mutant cannot interact with CNOT1
and TNRC6s
(Chen et al.,
2014)
Co-IP assay [Fig 2E,
4C, 4F]
6 CNOT9 (P165G, Y203A, R205A,
R244A) mutant cannot interact with
TNRC6s but interacts with CNOT1
(Chen et al.,
2014)
Co-IP assay, [Fig 4C,
4D]
7 DUF3819 domain of CNOT1 is not suf-
ficient for recruitment of TNRC6s (re-
quires WT CNOT9)
(Chen et al.,
2014)
Co-IP assay, [Fig 4C,
S5J]
8 DUF3819 (CNOT9 binding do-
main) interaction with TNRC6 SD is
strengthened in presence of CNOT9
(Mathys et al.,
2014)
Co-IP assay, [Fig 1E]
9 CNOT9 can directly interact with SD
in a W motif-dependent manner
(Mathys et al.,
2014)
Co-IP assay, [Fig 1E]
Table 3.1: Literature summary on protein-protein interactions involving
CNOT9
Based on these the above findings CNOT1∆C1−1585 (truncated CNOT1 lacking C-
terminal domain) should not interact with silencing domain of TNR6C in presence of
mutant CNOT9 that either compromises CNOT9-CNOT1 interaction or CNOT9-SD
interaction. This was not attempted by previous studies and remains to be tested.
In addition to this, we wanted to see the efficacy of CNOT1 and TNRC6 interactions
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in absence of any endogenous CNOT9. To do this, we decided to generate CNOT9
KO cell lines and test various aspects of the current model of CNOT9 dependent vs.
independent CNOT1-TNRC6 interaction. We further used KO cells to investigate the
contribution of CNOT9 in translation repression and decay of reporter mRNA.
3.2 Materials and Methods
3.2.1 Plasmids
Generation of Cnot9mut4 (H58A, F60A, A64Y, V71Y) and Cnot9GW182neg (P165G,
Y203A, R205A, R244A) constructs have been mentioned in Section 2.2.11 (Materials
and Methods, Chapter 2). These were used to generate EGFP-tagged Cnot9mut4 and
Cnot9GW182neg constructs in pEGFP-C1 vector by PCR based amplification. Plas-
mid expressing wild-type CNOT9, CNOT1, and truncated CNOT1(CNOT1∆C1−1585)
conjugated with EGFP was previously generated in the lab. FLAG-tagged human
TNRC6C silencing domain (amino acids: 1260-1690) was cloned into pcDNA3.0 vec-
tor between BamH1 and Xho1 sites. To investigate the role of CNOT9 in translation
repression and mRNA decay, Renilla luciferase containing let-7 miRNA interaction
element followed by polyadenylation signal-sequence was subcloned from pAWH-Rluc-
let-7-Poly(A) vector (Tomari Lab) to pcDNA3.0 vector at BamH1 and EcoR1 sites, to
ensure promoter compatibility for mammalian expression.
Figure 3.1: Strategy to generate MS2-tagged CNOT9 and mutants for teth-
ering assay Schematic representation of sites used for cloning Cnot9, Cnot9 mut4, and
Cnot9 GW182neg into pCMV14-MS2-W82R-NLS-3XFLAG vector
Likewise, Renilla luciferase containing let-7 miRNA interaction element followed by
A114-N40 (114 adenosines internalized by a 40 nt unrelated sequence) and a hammerhead
ribozyme sequence (HhR) was subcloned from pAWH-Rluc-let-7-A114-N40-HhR vector
48 Molecular interactions of mammalian CNOT9 protein
to pcDNA3.0 vector at BamH1 and EcoR1 sites. pcDNA3.0 vectors to pCMV14-MS2-
W82R-NLS-3XFLAG vector within EcoRV and BamH1 sites, in frame of upstream
MS2 element and downstream 3XFLAG tag. A schematic of this is shown in Figure
3.13.1. Bait construct for tethering assay containing Firefly luciferase followed by
nine MS2 stem loop elements was previously constructed in pCI-neo vector. Cloned
constructs were confirmed by DNA sequencing and expression in HEK293T cells.
3.2.2 Cell lines
Human cell lines HEK293T and HeLa were used for ectopic expression experiments.
CNOT9 KO cells were generated as mentioned in Section 2.2.12 (Materials and Meth-
ods, Chapter 2).
3.2.3 Reporter Tethering assay
CNOT9 KO HeLa cells were seeded in 12-well plates at a density of 105 cells/well. At
≈80% confluency, transfection was done in using TransIT-LT1 (Mirus Bio) reagent as
listed below:
Sl. No Particulars Volume/well
1 Opti-MEM media 100µl
2 Plasmid DNA* (each stocked at 1µg/µl)
[pCMV14-MS2-CNOT9/CNOT9GW182neg/CNOT9mut4 1µg
pCINeo-Firefly-Luc-9XMS2BS and pRenilla-Luc-TK]
3 TransIT-LT1 reagent 3µl
Total 103µl
* To ensure a total of 1µg DNA, 333µg of each plasmid was transfected
Components for transfection were added in the order indicated. Transfection mix
was incubated at RT for 20 mins before adding dropwise to cells. Luciferase assay was
done 24 hours post transfection using DLR Assay Kit (Promega) following manufac-
turer's protocol. Data was recorded using Centro LB 960 luminometer (Berthold).
3.2.4 Reporter Assay for miRNA mediated translation sup-
pression and mRNA decay
WT HeLa cells were maintained in 10-cm dishes prior to commencement of experi-
ment. Transfection of Control and CNOT9 siRNA was done following reverse transfec-
tion method, using Lipofectamine RNAi Max Kit (ThermoFisher) as mentioned below:
250µl of Transfection mix was added per well, followed by gentle swirling to ensure
even coating of bottom surface. Coated tissue culture plate was incubated for 5 minutes
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Sl. No Ingredients Volume/well
1 Opti-MEM media 250µl
2 Transfection Mix Control or CNOT9 siRNA* (50µM stock) 0.5µl
3 Lipofectamine RNAi Max 5µl
4 Cell suspension 750µl
**Total Volume (approximately) 1000µl
at RT inside laminar flow. Thereafter HeLa cells harvested from culture dishes were
seeded into wells coated with siRNA at a density of 5×104 cells per well and incubated
at 37oC for 36 hours. After 36 hours, media change was performed prior to Reporter
luciferase transfection. Recipe for transfection solution is tabulated below:
Sl. No Ingredients Volume/well
1 Opti-MEM media 100µl
2 pGL3.0 vector* (Stock Conc. = 1µg/µl) 0.9µl
3 RLuc-Let7-SynPolyA or RLuc-Let7-A114-HhR
(Stock Conc. = 1µg/µl)
0.1µl
4 Trans-IT reagent 2.0µl
**Total Volume (approximately) 103µl
Transfection mix was incubated at RT for 20 mins before adding dropwise to cells.
After 24 hours, cells were harvested, and luciferase assay was performed using DLR
Assay Kit (Promega) following manufacturer's protocol. Data was recorded using
Centro LB 960 luminometer (Berthold).
3.2.5 RNA and Protein Isolation
Total RNA was isolated from cells using Isogen II protocol as described previously in
Section 2.2.11 (Materials and Methods, Chapter 2). Protein isolation was done using
TNE buffer, composition and procedure of which has been described in Section 2.2.4
(Materials and Methods, Chapter 2). Methods used for protein co-immunoprecipitation
has been previously mentioned in Section 2.2.6 (Materials and Methods, Chapter 2).
3.2.6 Mass Spectrometry
Approximately 3mg of total protein was used for IP assays. Immunoprecipitated pro-
teins bound to antibody conjugated beads were solubilized in 1 ml of 50mM Ammonium
Bicarbonate (Ambic) solution (pH= 8.0) and centrifuged at 500g for 2 minutes at 4oC.
Supernatant was discarded, and washing was repeated. Thereafter, 100µl of 0.5M
NH4OH (pH = 11-12) solution was added to pellet, mixed gently and incubated at
RT for 5 minutes. This was followed by centrifugation at 500g for 2 minutes at 4oC.
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Supernatant was transferred into fresh Eppendorf tubes and procedure was repeated
to increase yield of immunoprecipitated proteins. Solvent removal was performed for
200µl of supernatant (that contained eluted proteins) using a SpeedVac or Rotavapor,
followed by resuspension of pellet (sticking to walls of tube, not visible) in 10µl of 4X
LDS buffer (ThermoFisher). Maximum resuspension was ensured by gently vortexing
tube on a shaking stand for 10 mins at RT. Thereafter, 5µl of 100mM Dithiothreitol
(DTT) was added to solution, followed by addition of MQ water to make a final volume
of 40µl. Samples along with protein Ladder were heat denatured at 75oC for 10 mins
before loading on pre-cast 4-12% gradient SDS-PAGE gels. Electrophoretic separation
of proteins in 1XMOPS buffer (ThermoFisher) was done at 200V for 50 mins to achieve
maximum separation. Post electrophoresis, gel was fixed using fixative solution (50%
MeOH in 10% Acetic acid solution) for 30 minutes under gentle shake. Thereafter gels
were stained with CBB Staining Solutions A and B (Nacalai) for 4 hours, followed by
destaining in MQ water to remove excess stain. Gels were imaged before excising out
protein bands across different lanes. Finally, trypsin digestion was performed overnight
at 37oC and post elution, digested peptides were injected into LC-ESIMS machine for
characterization.
3.2.7 Antibodies
Antibodies against CNOT1, CNOT3, CNOT6, CNOT6L and CNOT7 were generated
by Bio Matrix Research (Tokyo, Japan) as previously described (Chen et al., 2011).
Commercially available antibodies used for immunoblotting included: anti-a-tubulin
(Sigma, T9026), anti-CNOT9 (Proteintech, 22503-1-AP), anti-FLAG (MBL, PM020),
anti-EGFP (MBL, 598), anti-RNF219 (Bethyl A302-540A), anti-GW182 (Bethyl, A302-
329A), anti-CNOT2 (CST, 34214S), anti-4EBP1 (CST, 9644S), anti-b-Actin (CST,
4970L), anti-GAPDH (CST, 2118L), anti-CNOT10 (Bethyl A304-899A), and anti-
AGO2 (CST, 2897S). For western blotting, all antibodies were used at 1:1000 dilution
in 5% skimmed milk solution. For IP assay Anti-FLAG M2 Affinity gel (Sigma Aldrich,
A2220) was equilibrated in TNE buffer (10 mM NaF, 20 mM Tris-HCl, 150 mM NaCl,
2 mM EDTA, 1% NP-40, 1 mM PMSF, 10 mM β-glycerophosphate) prior to use.
3.2.8 siRNA
Double strand RNA oligonucleotides targeting the following cDNA sequences were
synthesized by Sigma Aldrich:
Sl. No Sequence Purpose
1 5'-UUCUCCGAACGUGUCACGU-3' Control siRNA
2 5'-CAUGCUGUGGCAUUCAUUUGG-3' CNOT9 siRNA #1
3 5'-GCUCUGGCAUUACUGCAAUGU-3' CNOT9 siRNA #2
4 5'-GGAAUCUGGAAGUGAACUUUC-3' CNOT9 siRNA #3
5 5'-CCUUCGACUCUCAGAUAAU-3' CNOT9 siRNA #4
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3.3 Results
3.3.1 Investigating CNOT9 interacting proteins
Using FLAG-CNOT9, FLAG-CNOT9mut4 and FLAG-CNOT9GW182neg proteins as bait,
we immunoprecipitated interacting proteins of CNOT9 and identified them by West-
ern Blotting and as shown in Figure 3.2. Identified proteins bound to FLAG-CNOT9
include, and not being limited to, CNOT1, CNOT2, CNOT6, CNOT6L, CNOT7 and
GW182 (TNRC6). CNOT9 mutant (CNOT9GW182neg), despite being incompetent for
direct interactions with GW182, co-immunoprecipitated the latter, possibly via indirect
associations with CNOT1. In other words C-terminal domain of CNOT1 may have fa-
cilitated interactions with GW182, when interactions via DUF3189 domain was likely
to be compromised by bound CNOT9GW182neg mutant. Furthermore, in agreement
with expectation, CNOT9mut4 due to lack of CNOT1 interaction failed to associate
with other components of the CCR4-NOT complex as well as GW182 protein (Figure
3.2).
Figure 3.2: CNOT9 interacting proteins in HeLa cells Western Blotting
based detection of proteins co-immunoprecipitated with FLAG tagged CNOT9,
CNOT9GW182neg, and CNOT9mut4, in wild-type HeLa cells.
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To validate the above result and have a comprehensive understanding of CNOT9
interacting proteins, we performed mass spectroscopic analysis of immunoprecipitated
fractions. Prior to mass spectrometric analysis, immunoprecipitated proteins in re-
spective fractions were resolved on 4-12% gradient gel was shown below (Figure 3.3).
IP using Rabbit anti-CNOT9 antibody in WT HeLa cells (lane 3, Figure 3.3) was also
tested alongside FLAG IPs.
A list of unique peptides corresponding to various proteins co-immunoprecipitated
by CNOT9 and its mutant isoforms were identified by LC-MS (Table 3.2). Besides
CCR4-NOT subunits, proteins TAB182(TNKS1BP1), RNF219, RAVER1, PRPSAP1,
NPM1, MTMR4, CAPZA, and CAPZB were found to interact with CNOT9 in a
CNOT1 dependent manner. Unfortunately, mass spectrometry could not detect unique
peptides corresponding to either GW182 or AGO2 proteins in any fraction.
Figure 3.3: In-gel separation of CNOT9 co-immunoprecipitated proteins.
Western Blotting based detection of proteins co-immunoprecipitated with FLAG
tagged CNOT9, CNOT9GW182neg, and CNOT9mut4, in wild-type HeLa cells.
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Accession Description Mol. Weight(kDa) Unique peptides in cells transfected with
pcDNA3 FLAG-
CNOT9
FLAG-
CNOT9GW182neg
FLAG-
CNOT9mut4
A5YKK6 CNOT1 266.8 0 73 53 0
B7Z1E5 CNOT9 36.8 0 24 24 25
Q9C0C2 TNKS1BP1 181.7 0 22 11 0
Q9UIV1 CNOT7 32.7 0 8 11 0
O75175 CNOT3 81.8 0 13 9 0
Q9H9A5 CNOT10 82.3 0 11 7 0
Q9NZN8 CNOT2 59.7 0 9 7 0
Q5W0B1 RNF219 81.1 0 13 6 0
B4DP31 PRPSAP1 31.2 0 6 5 0
Q9UFF9 CNOT8 33.5 0 5 4 0
Q9UKZ1 CNOT11 55.2 0 2 3 0
E9PAU2 RAVER1 79.5 0 1 2 0
B1AK88 CAPZB 33.8 0 2 1 0
Q9NYA4 MTMR4 133.3 0 1 1 0
H0Y9Z5 CNOT6L 63.7 0 1 1 0
Q96LI5 CNOT6 63.0 0 1 1 0
P52907 CAPZA 32.9 0 1 1 0
E5RI98 NPM1 11.9 0 1 1 0
Table 3.2: List of co-immunoprecipitated proteins detected by mass spec-
trometry Number of unique peptides corresponding to immunoprecipitated proteins
across various IP fractions, determined by mass spectroscopy
3.3.2 Contribution of CNOT9 in CNOT1-TNRC6 interaction
Based on preliminary evidence of CNOT9 interacting proteins, we investigated the
importance of CNOT9 in mediating interactions between CNOT1 and GW182 proteins
specially when C-terminal domain-based interaction is compromised. To test this,
we used a construct expressing truncated from of CNOT1(1-1585) lacking C-terminal
domain and fused with N-terminal EGFP (indicated as EGFP-CNOT1∆C). FLAG
tagged silencing domain of TNRC6C (GW182) protein was used as bait for IP assay
(indicated as FLAG-GW182-FL-SD). Based on results shown in Figure 3.4, it was
found that truncated CNOT1 protein interacted with silencing domain of TNRC6C
only when co-expressed with wild-type form of CNOT9. This clearly suggests the
importance of CNOT9 at its binding locus (DUF3819 domain), in facilitating efficient
interactions between CNOT1 and TNRC6C proteins.
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Figure 3.4: DUF3819 domain occupancy for CNOT1-GW182 interactions
CNOT1∆C protein Co-IP by FLAG-GW182 FL-SD in presence of CNOT9 and mu-
tants (CNOT9GW182neg and CNOT9mut4) in wild-type HeLa cells
3.3.3 CNOT1-TNRC6 interaction in CNOT9 KO HeLa cells
Despite the previous result, there exists a possibility of CNOT9 being structurally and
functionally dispensable for overall interactions between TNRC6C and CNOT1 pro-
teins.
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Figure 3.5: CNOT1-GW182 interactions in CNOT9 knockout condition
CNOT1-GW182 interactions in CNOT9 knockout condition
Hence, we re-investigated interactions between TNRC6C(GW182) and CNOT1 pro-
teins in a system completely devoid of CNOT9. Hence, we generated CNOT9 KO HeLa
cells using CRISPR-Cas9 technique and validated by western blotting (Figure 3.5A).
For interaction study, FLAG tagged silencing domain of TNRC6C (GW182) protein
was exogenously expressed in WT and CNOT9 KO HeLa cells and interacting proteins
were immunoprecipitated using anti-FLAG antibodies. Based on results shown in
Figure 3.5B, FLAG-tagged silencing domain could not immunoprecipitate CNOT1 and
CNOT3 proteins in absence of CNOT9. B-actin immunoblot served as a negative
control for IP assay and as a loading control for input fraction.
3.3.4 Contribution of CNOT9 in translation suppression and
mRNA decay
Role of CNOT9 in translation repression and mRNA decay was assessed in-vitro, us-
ing reporter tethering assay, as illustrated in Figure 3.6A. MS2-fusion proteins with
CNOT9 and mutant CNOT9 were validated by western blotting in WT HeLa cells as
shown in Figure 3.6B. Thereafter, contribution of wild-type CNOT9 and its mutant iso-
forms were compared by measuring reporter luciferase activity and expression levels in
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CNOT9 KO HeLa cells. As shown in Figure 3.6C, reporter activity was approximately
2-fold lower when tethered by MS2-tagged CNOT9 or MS2-tagged CNOT9GW182neg
mutant, compared to control. Additionally, MS2-tagged CNOT9mut4 mutant showed
no differences in tethering efficiency compared to MS2-only control suggesting that
CNOT9 interaction with CNOT1 is required for mediating translation suppression.
Furthermore, no differences in reporter mRNA levels of were observed across all four
experimental conditions, suggesting no significant contribution of CNOT9 in mRNA
decay (Figure 3.6C).
Figure 3.6: CNOT1-GW182 interactions in CNOT9 knockout condition(A)
Schematic representation of tethering MS2 tagged CNOT9 to reporter luciferase re-
porter containing MS2-binding sites (B) Validation of MS2 fusion protein expression
in WT HeLa cells by western blotting. Arrowheads represent bands corresponding to
various proteins (CNOT9, CNOT9-MS2, and MS2-FLAG), whereas non-specific bands
are indicated by * (C) Relative expression levels for Firefly LUCIFERASE reporter ac-
tivity and Firefly Luciferase reporter mRNA in CNOT9 KO cells transfected by MS2
fused CNOT9 or MS2 fused mutant CNOT9. Values are Mean ± SD [n=5, p < 0.01
(**)
3.3 Results 57
Next we analyzed the role of CNOT9 specifically in the context of microRNA me-
diated translation suppression. Luciferase-based reporter assay used to test this idea
has been illustrated in Figure 3.7A. In cells expressing CNOT9, luciferase reporter
conjugated with Let7 miRNA sites followed by a synthetic polyadenylation element, is
likely to undergo both translational repression and mRNA decay under steady state
conditions. On the other hand, luciferase reporter conjugated with Let7 miRNA sites
followed by a stretch of 114 adenosine residues attached to a deadenylation resistant
Hammerhead ribozyme motif element, should largely be susceptible only to transla-
tional suppression. Thus, by comparing differences in activities of both reporters, the
extent of translation repression can be assessed. Based on results shown in Figure
3.7C, depletion of CNOT9 by siRNA treatment, led to a significant ≈3-fold increase in
reporter luciferase activity for both reporters in a manner largely driven by translation
suppression. Cell lysates subjected to luminometric analysis were also used for western
blotting to confirm CNOT9 depletion as shown in Figure 3.7B.
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Figure 3.7: Reporter assay for miRNA induced translational suppression
and decay (A) Schematic representation of possible mechanisms of miRNA mediated
translational repression and mRNA decay using reporter constructs (B) Validation of
CNOT9 knockdown using 4 different siRNAs against CNOT9 alongside control. (C)
CNOT9 contribution in miRNA mediated translational repression and mRNA decay.
Values are Mean ± SD [n=4, p < 0.001 (***)]
3.4 Discussion 59
3.4 Discussion
In this section, we attempted to readdress the importance of CNOT9 in the context of
CNOT1-GW182 (TNRC6) interactions mainly to clarify certain contradictory obser-
vations made by previous studies. We also sought to investigate the role of CNOT9 in
mechanisms involving translation repression and mRNA decay, under in-vitro condi-
tions.
As a starting point, CNOT9 interacting proteins were identified by western blotting
and mass-spectroscopic analysis in HeLa cells. Majority of interacting proteins were ei-
ther core components of the multi-subunit CCR4-NOT complex, or non-core proteins
such as RAVER1 and RNF219, that have been known to associate with the com-
plex (Miyasaka et al., 2008, Youn et al., 2018). Western Blotting identified GW182
(TNRC6), a component of the miRNA-RISC complex, as an interaction partner of
CNOT9, although mass spectrometry analysis could not confirm unique peptides cor-
responding to the same. Further, AGO2 protein could not be detected in the pool of
CNOT9 interacting proteins either via western blotting or mass spectroscopy, possibly
due to poor sensitivity of the IP assay in identifying indirect interactions. It many
also be attributed to low-interaction/weak affinity of AGO2 towards the CCR4-NOT
complex under steady-state conditions. Such interactions may however be detected by
crosslinking protein lysates prior to antibody based immunoprecipitation steps. An-
other interesting observation was made with regard to CNOT4 protein. Our study
could not detect CNOT4 protein in IP fractions, although a recent study had reported
weak yet direct interactions between CNOT9 and CNOT4 proteins in human cells lines
(Keskeny et al., 2019).
Next, we investigated interaction between CNOT1 and FLAG-tagged silencing do-
main of TNRC6C protein. We found that CNOT1 could not interact with silencing
domain of TNRC6C protein in absence of CNOT9. This came as a surprise because,
a certain degree of interaction between CNOT1 and silencing domain of TNRC6C was
expected to occur via C-terminal domain of CNOT1 (Huntzinger et al., 2013). A
possible explanation for this result can be perceived as follows: CNOT9 binding to
CNOT1 allows the latter to adopt a stable conformation that favors interaction with
TNRC6C proteins. Further assessment and validation of interactions between CNOT1
and TNRC6 family of proteins needs to be done to address this hypothesis.
Using lysates from KO cell lines, we tested if CNOT9 contributed to structural
integrity of the CCR4-NOT complex. In previous studies, depletion of individual
CCR4-NOT subunits has been shown to compromise overall structural integrity of
the complex (Ito et al., 2011a, Ito et al., 2011b, Suzuki et al., 2015). In the same
vein, we tested if absence of CNOT9 also showed similar effects. WT and CNOT9 KO
cell lysates immunoprecipitated using anti-CNOT2 and anti-CNOT3 antibodies did
not show significant differences in IP efficiency of other subunits of the CCR4-NOT
complex (data not shown).
Lastly, we chose to investigate the role of CNOT9 in translation repression and
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mRNA decay with the help of two different luciferase-reporter based assays. It was
understood that CNOT9 operates mainly in the context of translation repression, in-
vitro. These observations need further testing and validation in different in-vitro and
in-vivo systems, primarily using untransformed cell-types or cell-lines that more closely
resemble physiological conditions. To conclude, CNOT9 is an important node between
two key cellular machineries  the CCR4-NOT deadenylase complex and the miRNA-
RISC complex, that is likely to support translation repression in higher eukaryotes.
Chapter 4
Molecular targets of CNOT9 in mouse
ES cells
4.1 Motivation
Phenotype exhibited by complete knockout and Sox2-Cre conditional knockout em-
bryos highlighted the importance of CNOT9 during gastrulation, more importantly in
differentiation of the epiblast lineage. However, at the point of phenotype emergence,
the epiblast lineage comprises of multiple heterogenous populations of lineage com-
mitted cell-types expressing divergent gene expression profiles (Peng et al., 2016). An
example of tissue heterogeneity can be reflected from differential expression levels of
FLK1 and PDGFRA that directs progenitor mesoderm cells towards extraembryonic
and lateral plate mesoderm (Flk1+/Pdgfra-), Cardiac mesoderm (Flk1+/Pdgfra+),
and Paraxial mesoderm (Flk1-/Pdgfra+) lineages (Kouskoff et al., 2005, Irion et al.,
2010). In another example, presence of retinoic acid gradient has been found to induce
heterogeneity in Fgf8 expression along anterior-posterior axis of embryos (Kumar and
Duester, 2014). Therefore, in the context of such non-uniformity, phenotype-based
bulk analysis is likely to yield a low-throughput landscape of gene expression. In other
words, a pan-embryo average measure of gene expression will not adequately reflect
differences that are region-specific or lineage-specific. One way to address this issue
involves analysis of gene expression profiles at single cell resolution (Cheng et al., 2019,
Pijuan-Sala et al., 2019). An alternate and more conventional approach involves in-
vitro stem-cell based derivation of specific cell-types and lineages.
Mouse embryonic stem cells (mESCs) have served as an excellent model to under-
stand gene expression and phenotype associated with early embryonic differentiation
(Evans and Kaufman, 1981, Martin, 1981, Prelle et al., 2002). They can be stably
propagated in culture conditions in presence of leukemia inhibitory factor (LIF) and
chemical inhibitors to Wnt and ERK signaling pathways (Smith et al., 1988, Williams
et al., 1988, Ying et al., 2008). ES cells have similar characteristics as that of pre-
implantation epiblast cells (Nichols et al., 2009). In addition, these cells are capable
of producing various cell types upon treatment with reagents that induce lineage spe-
cific differentiation. For instance, FGF signaling and retinoic acid treatment on mouse
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ES cells drives neuroectoderm differentiation whereas Wnt3a and activin treatment in-
duces differentiation in the direction of mesendoderm lineage (Yamaguchi et al., 1999,
Nishikawa et al., 2007, Niwa, 2007, Greber et al., 2010, Niwa, 2010). Likewise allowing
ES Cells to grow as aggregated embryoid bodies (EBs), have shown their ability to
differentiate into adult lineages such as hematopoietic, vascular, pancreatic, hepatic
and neuronal lineages (Murry and Keller, 2008).
We therefore chose to generate CNOT9 KO mESCs and use them to investigate
various phenotypic and molecular alterations under conditions of self-renewal and dif-
ferentiation. Using this simplified model, we aim to readdress KO embryo phenotype
and potentially use it to perform rescue experiments.
4.2 Materials and Methods
4.2.1 Derivation of CNOT9 KO mESCs
Our method for isolation and culture of mESCs has been adapted from Protocol #8 of
Chapter 4, and Protocols #6 and #7 of Chapter 8, of the textbook titled Manipulating
the Mouse Embryo (Behringer, 2014). Key procedures have been summarized as
follows:
Derivation of E3.5 blastocysts:
Ovulation was hormonally induced in four-week-old Cnot9 heterozygous Cnot9+/lacZ
female mice by 7.5U of Pregnant Mare Serum Gonadotropin (PMSG) administered
intraperitonially. This was followed by intraperitoneal administration of 7.5U of Hu-
man Chorionic Gonadotropin (HCG), 47 hours post PMSG injection. Immediately
thereafter, female mice were crossed overnight with Cnot9 heterozygous (Cnot9+/lacZ)
stud males. On the following day, vaginal plug positive females were identified. Two
days after plug sight, female mice were dissected and E2.5 morula stage embryos were
harvested by flushing oviducts with M2 media. Harvested embryos were transferred
into 1×KSOM media supplemented with GSK3β inhibitor (CHIR99021) and ERK in-
hibitor (PD0325901) and incubated overnight at 37oC, 5% CO2. On the following day,
embryos progressed to form E3.5 blastocysts.
Culturing blastocyst outgrowths over fibroblast feeder layers:
Twenty-four hours prior to blastocyst development, gamma irradiated mitotically ar-
rested mouse embryonic fibroblasts (MEFs) were seeded on gelatin coated 48-well plates
at a density of 2.5×104cells/cm2. Composition of media used to seed MEFs is men-
tioned below:
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Sl. No. Reagent Stock Conc. Add vol. (ml) Final Conc.
1 DMEM High Glucose - 500
2 Inactivated FBS 100% 50 10%
3 2-ME (Stock of 55mM in PBS) 1000x 0.5 0.1 mM
4 Penicillin/Streptomycin 100x 5 1x
5 Non-essential amino acids 100x 5 0.1 mM
6 HEPES, pH=7.5 1000 mM 0.5 ≈ 1 mM
On the following day, culture media for MEF feeders was replaced by complete mES
media (mES media supplemented with LIF and 2i), composition of which is tabulated
below:
mES media (Shelf life: 1month)
Sl. No. Reagent Stock Conc. Add vol. (ml) Final Conc.
1 KO-DMEM High Glucose - 500
2 KSR 100% 67
20%
3 FBS 100% 33
4 β-ME (Stock of 55mM in PBS) 1000x 0.6 0.1 mM
5 Penicillin/Streptomycin 100x 6 1x
6 Non-essential amino acids 100x 6 0.1 mM
7 L-glutamine 200mM 6 2 mM
Complete mES media (Shelf life: 1week)
Sl. No. Reagent Stock Conc. Add vol. (ml) Final Conc.
1 mES cell media - 50 ml
2 LIF (ESG1106, Millipore) 106 U/ml 75µl 1500 U/ml
3 2i* (CHIR99021) 30mM 5µl 3 µM
4 2i*(PD0325901) 10mM 5µl 1 µM
Two to three hours post media change, healthy blastocysts in KSOM+2i media were
seeded into individual wells of 48 well plate. Prior to seeding, blastocysts were rinsed
thrice in 100µl droplets of complete mES media, to ensure minimal media crossover.
Blastocyst quality was determined based on appearance of blastomeric cavity and po-
larization of inner cell mass (ICM cells). Blastocysts were cultured for 3-5 days until
outgrowths were seen.
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Derivation of ES cell colonies from blastocyst outgrowths:
Once outgrowths were observed, media change was carefully performed without displac-
ing colonies from underlying feeders. After 48 hours of culture, outgrowths were dis-
sociated by trypsinization followed by repeated rounds of pipetting to produce smaller
cell clumps consisting of 5-10 cells. Cell clumps were transferred into freshly seeded
MEF feeders on 48-well plates and cultured for 2-3 days until colonies emerged. As
colony size increased, ES cells were subsequently trypsinised and transferred into 24-
well plates, followed by 6-well plates and finally into 10-cm dishes. At every step, a
passage density of ≈1:6 was maintained.
Genotyping ES cell clones:
During passage of ES cells 6-well plates to 10-cm dishes, a fraction of them were seeded
on 35mm dishes for genotyping. These cells were plated on gelatin coated dishes lacking
feeder cells. Within 45-60 minutes of seeding, loosely attached and floating ES cells
were transferred into another gelatin coated 35mm dish, leaving behind a majority
of strongly adherent MEF feeders. This method was repeated once more to obtain
>90% enrichment in ES cells population. Enriched pools of ES cells were cultured
for an additional 24-36 hours to have sufficient lysates for PCR based genotyping and
western blotting.
Preparing frozen ES cell stocks:
Approximately 60-70% confluent ES cell colonies grown on 10cm culture dishes were
considered for cryo-preservation. ES cells were fed with fresh media 2-4 hours prior to
cell banking. Trypsinised ES cells along with feeder fibroblasts were resuspended in
cryopreservative solution composed of 10% DMSO and 90% complete mES media at a
density of ≈3.5×106 cells/ml. Cells were frozen overnight at -80oC, flowed by transfer
into liquid nitrogen tanks for long-term storage.
4.2.2 Retinoic acid (RA) induced differentiation of mES cells
ES cells were grown under feeder free conditions prior to RA induced differentiation.
Fibroblast depleted ES cells were seeded into 6-well tissue culture plates at a density
of 105 cells per well. After attaining 50% confluency, cells were cultured for 48 hours
in ES media lacking LIF and inhibitors. This refractory period allowed quenching
of LIF induced self-renewal and primed cells to undergo differentiation in subsequent
steps. After 48 hours, cells were treated with ES media (-LIF -2i) supplemented with
1µM retinoic acid. Cells were harvested at periodic intervals for study marker gene
expression upon RA treatment. A schematic of the aforementioned method is shown
in Figure 4.1.
4.2.3 Genotype confirmation by PCR and Western Blotting
Harvested ES cells were pelleted down by centrifugation at 300g for 4 minutes. Media
supernatant was removed, and pellet was subsequently resuspended in 1 ml of PBS.
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Figure 4.1: Protocol design for RA induced differentiation of mESCs
Resultant cell suspension was split into two tubes at 1:9 ratio. The smaller fraction
was lysed for DNA isolation while the other was considered for isolation of proteins as
detailed below:
DNA isolation:
100µl of cell suspension was pelted by centrifugation at 300g for 4 minutes and su-
pernatant was carefully discarded. Pellet was resuspended in 20µl of dilution buffer
followed by addition of 1µl DNA release solution provided in Phire Tissue Direct PCR
Kit (Thermo Scientific). Cell suspension was vortexed at maximum intensity for 10
seconds and incubated at room temperature for 5 minutes. Thereafter tubes were in-
cubated at 98oC for 3 minutes, followed by cooling on ice for 10-15 minutes. Resulting
lysate was used for PCR based genotyping at 1:10, 1:100, and 1:1000 dilutions.
Protein isolation:
900µl of cell suspension was pelleted by centrifugation at 300g for 4 minutes. After
carefully removing supernatant, cell pellet was resuspended in 100µl TNE buffer (10mM
NaF, 20mM Tris-HCl, 150mM NaCl, 2mM EDTA, 1% NP-40, 1mM PMSF, 10mM β-
glycerophsosphate). Cells were incubated for 15 minutes on ice with pulse vortexing
(2-3 seconds) every 5 minutes. Subsequently, lysates were contrifuged at 13000g for 10
minutes at 4oC and supernatant containing proteins were trnasferred into fresh tubes.
Total protein concentration was measured using BCA assay (ThermoScientific) and
adjusted to 1µg/µl using 3×Sample buffer.
4.2.4 Cell Growth Assay
Feeder subtracted mESCs were seeded on gelatin coated 6-well plates (TPP, Switzer-
land) at a density of 105 cells/well. Cell growth was monitored using IncuCyte S3
Live-Cell Analysis System (Essen Bioscience) while being incubated at 37oC, 5% CO2.
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4.2.5 Imaging ES cells colony
Blastocyst outgrowths and ES cell colonies were imaged using Leica TCS SP8 inverted
microscope.
4.2.6 qRT-PCR based gene expression analysis
RNA isolation and cDNA synthesis were done as described previously in Section 2.2.7
(Materials and Methods, Chapter 2). Primers used for real-time PCR are listed in
Table 4.1.
Sl. No Target Forward Primer (5'-3') Reverse Primer (5'-3')
1 Lefty1 actcagtatgtggccctgcta aacctgcctgccacctct
2 Lefty2 gccctcatcgactctaggc agctgctgccagaagttcac
3 Cyp26b1 ccaggactgtatgcccatga ccactcaccaacaaaaagacaag
4 Rarb cagaagtgctttgaagtgggc cgtctagctccgctgtcatc
5 Nodal tggtagggaagacccacaac tgccaagcatacatctcagg
6 Nestin tctgactctgtagaccctgcttc tctgactctgtagaccctgcttc
7 Oct4 aagttggcgtggagactttg tctgagttgctttccactcg
8 Pax6 cccggcagaagatcgtag tcacacaaccgttggatacc
9 Gapdh ctgcaccaccaactgcttag gtcttctgggtggcagtgat
10 Essrb atcaactgggccaagcac gaatctccatccaggcactc
11 Sox2 ggcagagaagagagtgtttgc tcttctttctcccagcccta
12 c-myc gtgctgcatgaggagacacc gcctcttctccacagacacc
13 Shh ttctgtgaaagcagagaactcc gacgtaagtccttcaccagctt
14 T atcaccagccactgctttcc cccggttcctccattacatc
15 Afp caaagccctacagaccatgaa ccgagaaatctgcagtgaca
16 Gata4 tcaaaccagaaaacggaagc cagacagcactggatggatg
17 Gata6 tggcacaggacagtccaag ggtctctacagcaagatgaatgg
18 Cnot9 gtctgcgcatcatggagtc aaccagtgtcatccaagagga
19 Pax3 agtatggacaaagtgcctttca tagtctgtggaggccggaaa
20 c-fos gttcctggcaatagtgtgttcca tgacaatgaacatggacgctga
21 Cebpa aaacaacgcaacgtggaga gcggtcattgtcactggtc
22 Wnt3a cttagtgctctgcagcctga gagtgctcagagaggagtactgg
23 Gsc gagacgaagtacccagacgtg gcggttcttaaaccagacctc
24 Sox7 cacgctgcctgagaaaaac gggagtactcacccctgtcc
25 Klf4 gctcctctacagccgagaatc atgtccgccaggttgaag
26 Nanog ttcttgcttacaagggtctgc cagggctgccttgaagag
27 Fgf8 caggtcctggccaacaag gtatcggtctccacaatgagc
28 c-jun agtagcccccaacctctttg gggacacagctttcacccta
Table 4.1: Primers used for qRT-PCR based gene expression in mESCs
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4.2.7 Antibodies
Commercially available antibodies used for immunoblotting included: anti-a-tubulin
(Sigma, T9026), anti-CNOT9 (Proteintech, 22503-1-AP), anti-GAPDH (CST, 2118L),
anti-LEFTY1/2 (SantaCruz, sc-365845), anti-LEFTY1 (CST, 12647), and anti-PARP
(CST, 9542S). For western blotting, all antibodies were used at 1:1000 dilution in 5%
skimmed milk solution.
4.3 Results
4.3.1 Characterization of CNOT9 KO mESCs:
ES cells grown under in-vitro culture conditions were routinely monitored and passaged
to maintain stemness. Expansion of ES cell clones from blastocysts outgrowth stage to
colony formation was recorded as shown in Figure 4.2A. Genotype of ES clones were
determined by analyzing PCR products on agarose gels as shown in Figure 4.2B. In
addition to that, genotype was also confirmed by western blotting using anti-CNOT9
and anti-β-galactosidase antibodies as shown in Figure 4.2C. A total of 18 different ES
clones were isolated and genotyped as indicated below in Table 4.2.
Sl. No. mES clone ID Genotype
1 H8 WT
2 H22 WT
3 H23 WT
4 H2 HE
5 H3 HE
6 H9 HE
7 H10 HE
8 H18 HE
9 H24* HE
10 H1 KO
11 H6 KO
12 H7 KO
13 H11 KO
14 H15 KO
15 H17 KO
16 H20 KO
17 H25 KO
18 H28 KO
Table 4.2: Genotypes corresponding to various mES cell clones
H24 clone (*) was slow growing and didn't have sharp colony boundaries.
Passage number for all clones at the time of freeze-stocking ranged from 6-8.
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Figure 4.2: Generation of ES cell colonies from blastocyst outgrowths and
genotyping (A) Brightfield images of ES cell colonies generated from blastocyst out-
growth after two passages. Scale: 0.2 mm (B) PCR based genotyping of CNOT9 KO,
HE and WT mES clones. Upper band corresponds to WT allele (416 bp) while lower
band corresponds to KO allele (296 bp). Upper band seen for KO clone at high den-
sity is likely to be contributed by residual feeder cells. (C) WT (H22, H23), HE (H2,
H3), and KO (H11, H15) clones confirmed by western blotting using anti-CNOT9 and
anti-β-galactosidase antibodies.
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4.3.2 Growth rates analysis of CNOT9 KO mESCs
ES cell growth was monitored while being cultured on gelatin coated TPP plates using
automated cell growth analysis setup (IncuCyte). Percentage confluence was used as
a measure of cell growth. As seen from Figure 4.3, preliminary results suggest similar
growth trends for WT, HE and KO mES cells.
Figure 4.3: Growth rate comparison between WT and CNOT9 KO mESCs
Cell growth kinetics for WT (clone H22), HE (clone H2) and KO (clones H11 and H15)
mES cells determined by measurement of % confluence over time. Values are Mean ±
SD. Inset plot indicates cell growth monitored over a total of 150 hours.
4.3.3 Gene expression in CNOT9 KO mESCs
Preliminary gene expression analysis was conducted for three different ES cell clones of
each genotype. qRT-PCR analysis and western blotting was done to investigate gene
expression at mRNA and protein level, respectively. At the outset, we investigated
mRNA levels of previously identified targets that were found to be upregulated in
CNOT9 KO embryos. ES cells cultured in-vitro have been known to express a subset
of gastrulation related targets such as Lefty1/2, Nodal among others (Besser, 2004,
Kim et al., 2014). As seen from Figure 4.4A, both Lefty1 and Lefty2 mRNA were
significantly upregulated in CNOT9 KO mES cells. Upregulation of lefty transcripts
was also reflected in protein levels as shown in Figure 4.4B and Figure 4.4C. No change
in Nodal mRNA expression was observed across genotypes (Figure 4.4A). Furthermore,
based on expression of cleaved PARP protein, KO ES cells did not show differences in
extent of cell death compared to controls (Figure 4.4B and Figure 4.4C).
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Figure 4.4: Relative expression of gastrulation related markers in CNOT9
KO mESCs (A) Relative expression levels for Lefty1, Lefty2, Nodal, and Cnot9 mRNA
in WT, HE and CNOT9 KO mESCs. (B) Protein expression levels for CNOT9,
LEFTY1/2 and PARP in WT, HE and KO mESCs. a-tubulin and GAPDH were
used as housekeeping controls. (C) Quantification of protein levels for LEFTY and
PARP proteins across genotypes. Values are Mean ± SD [n=3, p < 0.05 (*), p < 0.01
(**), p < 0.001 (***), NS (not significant)]
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Figure 4.5: Relative expression of other possible targets of CNOT9 in
mESCs qRT-PCR based relative expression levels for (A) pluripotency markers WT,
HE and CNOT9 KO mESCs. (B) Previously characterized RA and CNOT9 targets
(C) markers of ectoderm differentiation (D) markers of mesendoderm differentiation.
Values are Mean ± SD [n=3, p < 0.05 (*), p < 0.01 (**)]
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Self-renewal and stemness of CNOT9 KO ES cells were analyzed based on expres-
sion levels of Klf4, Nanog, c-myc, Sox2, Oct4, and Essrb mRNA. As seen from Figure
4.5A, no differences in transcript levels of stemness markers were observed in CNOT9
KO mESCs compared to WT and HE controls.
Based on the idea that CNOT9 acts a molecular intermediary in RA induced gene
expression, we performed preliminary expression analysis on a few previously identified
targets (Hiroi et al., 2002). As seen in Figure 4.5B expression levels of RA regulated
targets such as c-jun and Fgf8 were significantly altered in CNOT9 KO mESCs thereby
suggesting CNOT9 contribution in mediating effects of RA in mES cells.
Furthermore, basal expression levels for various Ectoderm markers and Mesendo-
derm markers were also compared between WT and CNOT9 KO mESCs, at non-
differentiating (stem) conditions. At the transcript level, no major change in expres-
sion of such markers were observed, with the exception of ectoderm marker Pax6 and
mesendoderm marker Gata4 (Figure 4.5C and Figure 4.5D).
4.3.4 RA induced differentiation of mESCs
Addition of RA to cultured ES cells has been known to induce neuroectoderm differ-
entiation, characterized by increase in receptors and enzymes required for RA intake
and activity alongside concomitant loss of pluripotency (Stavridis et al., 2010, Zhang
et al., 2015). In our attempt to investigate RA induced differentiation of CNOT9 KO
mESCs, we first standardized a protocol for monitoring gene expression dynamics upon
RA treatment using WT mESCs, details of which are indicated in Section 4.2.2 (Mate-
rials and Methods, Chapter 4). Based on data shown in Figure 4.6, our protocol could
efficiently capture ES cell responsiveness to RA.
Loss of pluripotency was confirmed by reduced expression ofKlf4 and Nanog mRNA
levels while neuroectodermal fate was reflected by increased expression of Nestin and
reciprocally reduced expression of mesoderm markers  Lefty1, Lefty2 and Nodal. Rarb
and Cyp26b1 expression served as positive controls for RA treatment. Cnot9 expression
was reduced during initial phase of RA treatment although levels recovered during later
stages of differentiation.
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Figure 4.6: Dynamics of gene expression in mESCs upon RA treatment
Relative expression levels of CNOT9 and other targets during time course of 1µM RA
induced differentiation of WT mESCs. Values are Mean ± SD [n=3]
4.4 Discussion
Mouse ES cell based in-vitro model was successfully generated to investigate molecular
function of CNOT9 keeping in consideration KO embryo phenotypes during gastrula-
tion. ES cells were morphologically characterized by rounded colonies grown on feeder
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fibroblasts and subsequently confirmed for high expression levels of stemness markers
relative to fibroblasts and other cell-types. CNOT9 KO mES cells were viable and
showed growth rates comparable to WT and HE controls. State of pluripotency (de-
termined by stemness marker expression levels) of KO cells was also comparable to
WT and HE clones. In other words, CNOT9 is dispensable at the level of ES cells
although its requirement along various courses of differentiation remains to be seen.
Based on preliminary molecular characterization, CNOT9 KO ES cells showed el-
evated expression levels for Lefty1 and Lefty2 transcripts compared to WT and HE
controls. This was in agreement with in-vivo results obtained from KO embryos. In
addition, loss of CNOT9 resulted in upregulation of downstream effectors of retinoic
acid such as c-jun and Fgf8. The motivation behind investigation of such targets came
from a previous study that deemed CNOT9 as a RA-inducible gene (Hiroi et al., 2002).
Interestingly, increase in c-jun expression in KO mESCs was contrary to expectation
as previous report suggested CNOT9 as a positive modulator of c-jun transcription in
F9 cells (Hiroi et al., 2002). On the other hand, Fgf8 expression levels in absence of
CNOT9, fits the narrative of being an reciprocally induced by retinoic acid (Kumar
and Duester, 2014). In summary, such preliminary findings need further investigation
to identify mechanisms of CNOT9 action on its targets.
After successfully isolating and propagating ES cells in-vitro, a protocol for induc-
ing stem cell differentiation was standardized. Our method involved a refractory period
of 48 hours to allow cells to transition from a state of self-renewal to lineage-specific
differentiation. During this period, intracellular effects of LIF, GSK3b inhibitor and
ERK inhibitor were quenched and cells were primed to undergo differentiation in pres-
ence of appropriate ligands.
In future, we plan to perform comprehensive gene expression analysis to identify
CNOT9 targets under various condition of ES cell differentiation. It would be worth
investigating phenotypic and molecular overlap between differentiating CNOT9 KO ES
cells (in-vitro) vs. gastrulation stage KO embryos (in-vivo). In other words, CNOT9
KO and control ES cells shall be compared in terms of their ability to undergo lineage
differentiation under in-vitro conditions. We expect to observe induction of cell death
in CNOT9 KO ES cells when subjected to one or more forms of lineage commitment
in agreement with KO embryo phenotype, in-vivo.
Chapter 5
Conclusions and Future Work
"It's not birth, marriage, or death, but gastrulation which is truly the
most important event in your life."
Prof. Lewis Wolpert
(founding father of modern developmental biology)
The above quote emphasizes the importance of gastrulation, a process that occurs
during very early stages of embryonic development in humans. During this process,
few hundreds of cells within an embryo attain distinct fates that eventually specialize
to form the brain, heart, stomach, limbs, and all other aspects that make us a bio-
logical entity. In other words, this is what separates us from being a ball of cells to
one of the most complex life forms on earth. At the molecular level, gastrulation is a
well-controlled scheme of events where gene expression in one set of cells determines
the fate of others, and vice-versa. However, our current understanding on specifics
of such gene expression dynamics is very limited and largely scattered. A majority
of existing studies till date have identified transcription regulation as a key determi-
nant of that drives modulates gene expression during gastrulation. In our attempt, we
focused on the aspect of post-transcriptional regulation of gene expression primarily
contributed by the decay of messenger RNA, during the course of embryonic gastrula-
tion. These mechanisms are regulated by the activity of a cellular complex known as
the CCR4-NOT complex. With remarkably high structural similarity and functional
conservation of this complex, laboratory mice serve as an excellent model to understand
similar phenomena that occur in humans. In our research we investigated the phys-
iological role of CNOT9, a subunit of the CCR4-NOT complex. Its significance was
reflected from the observation that mice lacking CNOT9 expression undergo develop-
mental arrest during gastrulation leading to embryonic lethality prior to mid-gestation.
We showed that phenotype of CNOT9 KO embryos was primarily contributed by
defects in the epiblast lineage. This was also in agreement with b-galactosidase staining
data that showed major expression in epiblast derived regions of the embryo between
embryonic days 7.5 to 8.5. At the molecular level, CNOT9 KO embryos showed signif-
icantly high expression of Lefty1, Lefty2, and c-myb mRNA, among others. Using an
in-vitro model we showed that this increase is contributed by impairment in mRNA
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decay. In future, it would be worth the while to generate an in-vivo model, to support
the current hypothesis. Generation of mice expressing mutant CNOT9 (Cnot9mut4),
that cannot interact with CNOT1, would be an ideal step in this direction. Depending
on phenotype exhibited by these mice, the role of CNOT9 as part of the mRNA decay
complex would be precisely established.
In an attempt to rescue knockout embryo phenotype, we had also generated a
lentivirus-based complementation system that induced CNOT9 expression specifically
within trophoblast derived placental tissue. To our surprise, we found that CNOT9
overexpression within the placental lineage highly correlated with developmental re-
tardation/defects in the adjoining epiblast-derived embryo proper. It is likely that
CNOT9 overexpression at low expressing/ectopic sites leads to dominant-negative ef-
fects that gets manifested at the physiological level. Use of a relatively mild or con-
trolled over-expression system is likely to can potentially serve as an effective tool to
examine rescue effects. Currently, lack of a pan-placenta specific promoter driven Cre
recombinase model, limits our understanding of placental genetics and its contribution
to embryo development. This issue can be addressed by in-silico promoter/enhancer
capture using CAGE (Cap Analysis of Gene Expression) technology on bulk or single-
cell cDNA libraries generated from cells or placental lineage. Identified promoters and
enhancers may thereafter be used to generate Cre knock-in mice that can support pla-
centa specific depletion of a target genomic region of interest.
Alternatively, the Sox2-Cre system can also be utilized to generate placenta specific
depletion of a given gene of interest. This involves generation of a transgenic mouse line
that contains a stop codon flanked by loxP elements inserted within a given exon. Cre
expressing embryos will recombine loxP sites and therefore remove the stop codon and
help generate a functional form of the gene throughout the epiblast. Due to absence of
Sox2 dependent Cre activity within the placental lineage, these tissues will not express
the exon of interest and a placenta-specific loss-of-function effects can be investigated.
To have a comprehensive understanding of CNOT9 function along various forms
of embryonic lineage commitment and differentiation, we generated knockout ES cells
as an in-vitro model. As a preliminary observation, loss of CNOT9 did not show any
distinct phenotype in terms of cell growth and viability under growth conditions that
support stemness and self-renewal. We expect to observe an indispensable requirement
of CNOT9 in one or more forms of ES cell differentiation, that can explain in-vivo
phenotype of KO embryos that undergo developmental defects followed by cell death
during gastrulation.
We also evaluated existing models and theories relating to the molecular function of
CNOT9, in ways that have not been tested before. In our experimental conditions we
observed that, in absence of CNOT9, flag-tagged silencing domain of GW812 could not
associate with CCR4-NOT subunit CNOT1. This observation was made in a trans-
formed cell line (HeLa) that has been in culture for many years and is therefore less
likely to be a representative physiological model. Hence, additional experiments using
in-vitro systems such as KO ES cells, shall help in developing a more concrete under-
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standing on this aspect of CNOT9 function.
In summary, our study presents novel insights on the role of CCR4-NOT complex
in regulating gene expression control during gastrulation via subunit CNOT9.
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